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ABSTRACT
Arachidin-1 (Ara-1) and arachidin-3 (Ara-3) are stilbenoids found in hairy peanut roots,
which have been shown to possess similar, if not higher, efficacy in biological activities when
compared to nonprenylated analogs such as piceatannol and resveratrol. Blackberry essences are
concentrated volatiles, which are characterized by low molecular weight, lipophilic properties,
and have also been demonstrated to have health benefits. As interest in dietary bioactive
compounds functional ingredients increase, more emphasis has been placed on identifying which
compounds have high efficacy as well as bioavailability. The ability of a compound to exert its
health promoting effects depends on its bioavailable dose, rather than the administered dose. The
present study aimed to evaluate the stability of Ara-1 and Ara-3 under cell incubation conditions
and attempts to determine bioavailability of Ara-1, Ara-3, and blackberry essences using an in
vitro Caco-2 transport assay. Caco-2 cells were seeded on semipermeable membranes and
allowed to differentiate into a morphology that resembles mature small intestine enterocytes.
Sample preparation, extraction methods, and enzymatic treatments were adjusted to enhance
recovery of Ara-1 and Ara-3. However, Ara-1 was shown to be more susceptible to the effects of
oxidation and degradation. At this time, it is inconclusive whether Ara-1 and Ara-3 possesses
higher bioavailability than its analog, resveratrol (Resv), in cell incubation conditions due to
little to no recovery during transport. On the other than, individual volatiles from the blackberry
essences were tentatively identified and transport rates determined based on the peak area found
in the starting material. Results suggests that though esters and monoterpenes make up the two
most abundant functional groups in the blackberry essence profile, higher transport rates and
recovery were observed in aldehydes.
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CHAPTER 1
Introduction

Bioactive compounds are essential and non-essential compounds that are usually present
in small quantities as natural constituents in food and can be shown to exert a wide range of
biological activities in the human body (Biesalski et al. 2009). Previous epidemiological studies
have shown that the consumption of plant-derived bioactive compounds play an important role in
the protection of humans from various degenerative diseases. For the past 30 years, public
interest in foods that provide health benefits beyond basic nutrition has increased dramatically
due to several factors, including an increase in healthcare costs and the desire to improve
personal health (Kris-Etherton et al. 2002, Luthria 2006). The basis, however, is mainly due to
knowledge of the association between protective properties of plant-based diets and a decreased
risk of chronic diseases such as cancer and cardiovascular disease.
Berry fruits are a rich source of essences (concentrated volatiles), antioxidants, and
polyphenols such as anthocyanins and phenolic acids (Nile and Park 2014, Szajdek and
Borowska 2008). Blackberries, in particular, have shown to possess anti-inflammatory properties
by inhibiting nitric oxide production as well as protecting against age-related diseases such as
neurodegeneration (Skrovankova et al. 2015). Peanut plants (Arachis hypogaea L.) contain
stilbenoids such as arachidin-1 (Ara-1) and arachidin-3 (Ara-3), which have also been shown to
confer antioxidant and cancer-protective properties.
Current research efforts are focused not only on the development of health-promoting
foods for health maintenance throughout the life cycle, but also on researching bioactive
components to evaluate the necessary dosage for optimum health. Bioavailability, or the rate and
extent to which the active ingredient or active moiety is absorbed from food and becomes
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available at the site of action, depends on a compound’s overall absorption in the body.
The ability of a compound to exert its biological effects depends on its bioavailable dose, rather
than the administered dose. To date, there has been no research performed on the bioavailability
of berry volatile extracts or Ara-1 and Ara-3. Understanding how these compounds are absorbed
and discerning its fate in the body is an important step to determining how readily they may exert
biological effects. Therefore, the goal of this proposed research is to determine the in vitro
bioavailability of blackberry volatiles, arachidin-1 (Ara-1) and arachidin-3 (Ara-3) to better
understand their health-promoting properties. The hypotheses are that 1) Ara-1 and Ara-3 will
possess higher absorption potential and subsequent bioavailability than its analog, resveratrol
(Resv), due to the presence of prenylated moieties and 2) blackberry volatiles will possess a
moderate to high absorption potential and subsequent bioavailability due to the volatiles’ low
molecular weight and lipophilicity. The objectives of this study are to 1) evaluate the stability of
Ara-1 and Ara-3 and identify the components of blackberry essences, 2) assess the
bioavailability of Ara-1 and Ara-3 by measuring their uptake and transport across the Caco-2 cell
monolayer and (3) assess the bioavailability of blackberry volatiles by measuring and identifying
compounds transported across the Caco-2 cell monolayer.
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CHAPTER 2
Literature Review
Bioactive Compounds in Foods
Bioactive compounds are essential and non-essential compounds (e.g., vitamins or
polyphenols) that occur in nature and can be shown to have an effect on human health (Biesalski
et al. 2009). The majority are found in foods that predominantly originate from the plant
kingdom - in various fruits, vegetables and grains - with some others from animal sources (Rein
et al. 2013). Bioactive compounds vary widely in their chemical structures and functions; as
such, they are categorized accordingly (Kris-Etherton et al. 2002). Several examples of plantderived bioactive compounds include polyphenolics, organosulfur compounds, phytosterols,
carotenoids and monoterpenes - all of which have subcategories exhibiting a diverse range of
chemical and biological properties (Kris-Etherton et al. 2002). They may also differ in attributes
regarding sites of action, distribution in nature, and concentrations in foods as well as the human
body (Carbonell-Capella et al. 2014).

Polyphenols
Polyphenols are present in all plants and have been extensively studied for its health
effects in a variety of food sources such as legumes, nuts, vegetables, fruits, tea and red wine
(Kris-Etherton et al. 2002). They are products of secondary metabolism during normal plant
development in addition to acting as a defense mechanism against stressors and contributing to
the coloration of plants (Liu 2013). Recent interest in polyphenols are manifold but are largely
due in part to its antioxidant properties, ubiquitous abundance throughout the human diet, and
their potential role in the prevention of degenerative diseases associated with chronic oxidative
stress (Manach et al. 2004).
3

Classification
Polyphenols are extremely diverse, comprising more than 8,000 identified structures that
vary from simple molecules to complex polymeric structures (Kris-Etherton et al. 2002). They
are further categorized into non-flavonoids and flavonoids on the basis of the number of phenol
rings they contain as well as the structural elements that bind them together (Manach et al. 2004).
Non-flavonoids consist of phenolic acids, stilbenes (resveratrol, piceatannol, arachidin-1, and
arachidin-3), lignans, and tannins (Manach et al. 2004). Flavonoids, on the other hand, can be
further subdivided into classes consisting of more than 5,000 compounds, representing the most
common group of phenolic compounds found in plant foods (Kris-Etherton et al. 2002). They
share a common structure of two aromatic rings (A and B) that are bound by 3 carbon atoms,
resulting in the formation of an oxygenated heterocycle (ring C) (Manach et al. 2004).
Depending on the function of the heterocycle, flavonoids are classified as flavonols, flavones,
isoflavones, flavanones, anthocyanidins, and flavanols, such as catechins and proanthocyanidins
(Manach et al. 2004). Recently, a review reported that the intake of dietary flavonoids in
Australian, European and US adult populations was between 209 to 1017 mg/day (mean 435
mg/day) (Kent et al. 2018). The variability may be attributed to access to different food supplies
and different cultural eating habits (Kent et al. 2018).
The human diet is not only a means of providing sufficient nutrients for metabolic
requirements, but can also be capable of providing numerous health benefits (Biesalski et al.
2009). Previously, epidemiological studies have shown that a diet based on plant-derived foods
with high amounts of polyphenols may help reduce the risk of chronic diseases such as
cardiovascular disease, diabetes and cancer (Liu 2003). In the last three decades, the general
population’s interest in functional foods, or foods that provide health benefits beyond basic
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nutrition, has increased dramatically, thereby reflecting a change in the overall role of nutrition
for the future (Luthria 2006). The resulting consumer demand for functional foods can be
attributed to several factors, including an increase in healthcare costs, desire to improve personal
health, and epidemiological evidence showing the association between protective properties of
plant-based diets and a decreased risk of chronic disease (Kris-Etherton et al. 2002, Luthria
2006). Therefore, current research efforts are directed towards the development of healthpromoting and functional foods for health maintenance throughout the life cycle (Rein et al.
2013).
Health Effects of Polyphenols
Cardiovascular disease (CVD) and cancer are the top 2 leading causes of death in the
United States (CDC 2015). Approximately 610,000 men and women die from heart disease each
year, while cancer collectively claims the lives of more than half a million Americans in the
same time frame (CDC 2015).
Since both CVD and cancer relate to diet, researchers have investigated the role of
dietary antioxidants in mitigating oxidative stress. Oxidizing agents may be attributed to
intracellular metabolic activities within organisms, or they may be found in food, water, and air
(Liu 2003). Though some oxidizing agents are necessary for life, it is important to maintain
balance between oxidants and antioxidants for the purpose of optimal physiologic conditions in
the body (Liu 2003). Oxidative stress results from the overproduction of oxidants, which can
cause damage to biomolecules such as DNA, protein, and lipids, leading to an increased risk of
CVD and cancer (Liu 2003). Fruits, vegetables and beverages like tea and wine contain a vast
variety of polyphenols that can offset oxidative damage in cellular systems by mechanisms such
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as activating signaling pathways that lead to upregulation of the expression of detoxifying
enzymes (Liu 2003, World Cancer Research Fund, 2007).
Extensive studies have been undertaken to explore the link between dietary intake of
polyphenols and reduced risk of CVD. A cohort study by Knekt and colleagues (1996) studied
the association between intake of flavonoids and coronary mortality from 1967-1992 in 5133
Finnish men and women. The subjects ranged from ages 30-69 years and were free from heart
disease at baseline. The results indicated that people with very low dietary intakes of flavonoids
have a higher risk of coronary heart disease. Apples and onions, rich in the flavonoid quercetin,
represented 64% of the subjects’ total dietary intake and were inversely associated with total and
coronary mortality. Researchers suggest that the mechanism of protection may be attributed to
antioxidative effects or the inhibition of thrombogenesis (Knekt et al. 1996). Additionally, a
study by Lekakis and colleagues (2005) found that red grape polyphenolics acutely improved
endothelial function in 30 male patients with coronary artery disease (Lekakis et al. 2005).
Subjects were either administered 600 mg of red grape extract dissolved in 20 mL of water, or 20
mL of water as the placebo. The extract contained 4.32 mg epicatechin, 2.72 mg catechin, 2.07
mg gallic acid, 0.9 mg trans-resveratrol, 0.47 mg rutin, 0.42 mg epsilon-viniferin, 0.28 mg, pcoumaric acid, 0.14 mg ferulic acid and 0.04 mg quercetin per gram (Lekakis et al. 2005).
The American Institute for Cancer Research and World Cancer Research Fund (2007)
reported that an estimated 30-40% of all cancers can be prevented from lifestyle habits and diet
alone. The relationship between intake of antioxidant flavonoids and risk of cancer was
investigated in a prospective study from 1967-1991 amongst 9959 Finnish men and women aged
15-99. Their findings revealed an inverse association between flavonoid consumption and
incidence of all sites of cancer combined. More specifically, the consumption of apples shared an
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inverse correlation with subsequent incidences of lung cancer (Knekt et al. 1997). In another 8year prospective cohort study of postmenopausal women, it was found that those who consumed
>2 cups of non-herbal tea - mainly black tea - had a slightly lower risk for all cancers compared
with women who either never consumed or only occasionally consumed tea (Zheng et al. 1996).
Tea contains a vast array of antioxidative phenolic compounds such as catechin, epicatechin,
epicatechin gallate, epigallocatechin, and epigallocatechin gallate (Bhagwat et al. 2003).
Depending on whether or not the tea leaves are fermented, other active components can include
theaflavins and thearubigins (Bhagwat et al. 2003). The length of fermentation dictates what kind
of tea will be produced. For example, green tea is not fermented and contains mostly catechins,
while black tea is fully fermented and contains mostly thearubigins and theaflavins (Bhagwat et
al. 2003).
Volatiles
Volatile compounds are generally lipophilic compounds with a low molecular weight
(<300 Da) that vaporize readily at room temperature due to high vapor pressure (Kalua et al.
2007). If the compound is sufficiently volatile, it is perceived as a smell or odor after it reaches
the olfactory epithelium, dissolves into the mucus, and bonds with olfactory receptors (Kalua et
al. 2007). The most well-known volatile organic compounds (VOCs) are industrial solvents, with
many of them being widely use in commercial applications (Pennerman et al. 2015). However,
solvents such as benzene, toluene, glycol ethers, chloroform and others have been linked to both
long-term and short-term negative effects on human health (Pennerman et al. 2015). On the other
hand, little is known about the potential effects on human health – negative or beneficial - of
biogenic VOCs (Pennerman et al. 2015). Biogenic VOCs produced by plants are considered
secondary metabolites that are not directly involved in the growth process, but serve to help the
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plant survive in its environment. More than 100,000 chemical products are known to be
produced by plants, and 1,700 of these are categorized as volatiles (Spinelli et al. 2011).
Throughout time, it has been known that both floral and vegetative parts of plants emit
unique smells that have been used to enhance the quality of foods. Since then, they have
remained commercially important to the food, pharmaceutical, agricultural and chemical
industries as flavorants, drugs, pesticides and feedstocks (Schwab et al. 2008). Not only do VOCs
possess the ability to attract pollinators, but they also exhibit anti-microbial and/or anti-herbivore
activity, modulate acquired resistance to pests, and protect the plants’ reproductive parts from
external threats (Aprea et al. 2015, Dudareva et al. 2004). Fruits, in particular, produce a wide range
of volatile compounds that contribute to the fruits’ characteristic aroma and flavor (El Hadi et al.
2013). Such compounds are biosynthesized through metabolic pathways during the growth,

harvest, post-harvest, and storage phases, reaching their highest concentrations during ripening
(Yang et al. 2009).
Classification
Plant-derived VOCs can be categorized based on their chemical structures. They are
mainly comprised of terpenoids, esters, aromatics, amines, alcohols, aldehydes, ketones,
lactones, thiols, and other miscellaneous compounds. Terpenoids, an important contributor to
flavor and aroma in many fruits, are responsible for the smells given off by plants such as pine
trees (pinene), ginger (zingiberene), and citrus fruits (limonene) (El Hadi et al. 2013). A single
fruit can possess a high number of volatiles that span a wide range of chemical structures.
Apples, for example, have been reported to contain over 300 volatiles, with esters being the most
abundant volatile compound found within (El Hadi et al. 2013). Volatiles may also be expressed
in different concentrations and identities between cultivars. The unique aroma of “Fuji” apples
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are largely due in part to ethyl 2-methyl butanoate, 2-methyl butyl acetate, and hexyl acetate,
while hexyl acetate, hexyl 2-methyl butanoate, hexyl hexanoate, hexyl butanoate, 2-methylbuutyl
acetate, and butyl acetate are the most prominent volatile compounds in “Pink Lady” cultivars
(El Hadi et al. 2013). Blackberry volatiles, on the other hand, are mostly comprised of esters and
aliphatic alcohols, followd by terpenic and aromatic compounds, aldehydes, and ketones. A total
of 74 volatiles were identified an characterized based on GC and MS data in a recent study
performed by D’Agostino and colleagues (2015).
Health Effects of Volatiles
The attempt to discern the role of plant volatiles beyond its flavor-contributing attributes
has gained momentum in recent years. As such, research studies that explore the potential of
volatiles to exert biological and pharmacological activities in human health have begun to
emerge. In a study by Hannemann and colleagues (2014), it has been shown that aromatic
aldehydes such as o-vanillin markedly reduces the complications of sickle cell disease by
inhibiting polymerization, maintaining red blood cell hydration, and reducing the concentration
of sickle hemoglobin (Hannemann et al. 2014). Additionally, phenolic acids and monoterpenes
found in Asian medicinal mushrooms have also been found to exhibit antioxidant and
antimicrobial properties. For example, cinnamic acid and one of its metabolites have minimum
inhibitory concentrations (IC50) of 0.7~30 μg/mL against certain bacteria and fungi, while those
of monoterpenes alpha-terpineol and linalool against pathogenic and spoilage-forming bacteria
range from 0.5%-2% (Pennerman et al. 2015). In another study by Hirota and colleagues (2010),
the anti-inflammatory effects of limonene, a cyclic terpene commonly found in citrus fruits, on
human eosinophilic leukemia HL-60 clone 15 cells was investigated. Results show that limonene
could have potential anti-inflammatory efficacy in the treatment of bronchial asthma by

9

inhibiting cytokines, reactive oxygen species production, and inactivating eosinophil migration
(Hirota et al. 2010).
Overview of Bioavailability
The ability of a bioactive compound to exert its health-promoting effects upon a living
organism depends on its bioavailable dose instead of the administered dose (Holst and
Williamson 2008). The bioavailable dose is a more accurate representation of what the body is
capable of absorbing, distributing, metabolizing and excreting (ADME) as opposed to what is
administered or how much of a compound is present in specific foods. Understanding this
concept is integral to optimizing diets and setting appropriate recommendations for human
consumption (Caballero et al. 2015). The extent to which a compound will be present in
appropriate concentrations at its site of action depends on a variety of factors including dose,
formulation, the route of administration, the rate and extent of absorption, distribution through
systemic circulation, biotransformation, and excretion (Caldwell et al. 1995). As a result, the
term “bioavailability” was introduced to quantitate the fraction of administered compound that is
made available to the body.
Definition of Bioavailability
According to the FDA, bioavailability is defined as “the rate and extent to which the
active ingredient or active moiety is absorbed from a drug product and becomes available at the
site of action” (FDA, 2016). However, the scope of bioavailability is not just limited to the
common oral route of administration for both drugs and bioactive food compounds; in fact, how
a dosage form is introduced to the body can have various implications on bioavailability. Routes
of administration can either have a systemic effect when delivered enterally (drug placed directly
into the gastrointestinal tract) and parenterally (drug bypasses gastrointestinal tract by being
placed directly into systemic circulation), or a local effect (such as when a substance is applied
10

topically where the effect is desired) (Verma et al. 2010). Enteral routes include oral, sublingual,
and rectal methods, while parenteral routes include injecting drugs intravascularly,
intramuscularly and subcutaneously, or without injections via inhalation (Verma et al. 2010).
Each route possesses a different onset of action, or the length of time needed for a drug to exert
its effect, and are unique in its advantages and limitations. For example, compounds
administered orally are convenient, but must undergo first pass metabolism in which intestinal
and hepatic degradation can greatly reduce its concentration before reaching systemic
circulation. Oral routes of administration may have average onset of action of 30-90 min ,
whereas inhalation of gaseous and volatile agents is preferred for drugs that are easily degraded
in the gut (Verma et al. 2010). In this way, the compound bypasses first pass metabolism and
leads to a more rapid onset of action - usually 2-3 min - due to ease of access into circulation
(Verma et al. 2010).
The aforementioned definition of bioavailability is slightly modified to encompass the
four stages of ADME from a nutritional standpoint: an emphasis on the oral route of
administration through consumption, distribution through systemic circulation to targeted tissues
and organs, metabolism through biotransformation, and urinary or fecal excretion (Kussmann et
al. 2007).
Compared with pharmaceutical drugs, the bioavailability of polyphenols is difficult to
discern due to the complexity of food compounds, factors affecting the digestive process, and
different absorptive mechanisms involved with water soluble and lipid soluble molecules (Rein
et al. 2013). Additionally, unlike macronutrients, the bioavailability of polyphenols can vary
widely after ingestion. Protein, fat and carbohydrates have a higher rates of absorption and
utilization - usually more than 90% of the amount ingested - resulting in a higher bioavailability

11

(Caballero et al. 2015). This is due to many active transport systems in the body for fatty acids,
amino acids, small peptide and sugars, which allows macronutrients to be readily absorbed and
distributed throughout the body (Caballero et al. 2015). Bioavailability is an essential step in
researching functional foods and its associated health claims to evaluate the necessary dosage for
optimum health, as the biological properties of bioactive compounds depend on their absorption
in the gut and subsequent bioavailability.
A prerequisite to assessing bioavailability is bioaccessibility, or the fraction of a food
constituent that, as a result of being released from the food matrix, becomes present in the gut
and may pass through the intestinal barrier (Saura-Calixto et al. 2007). A compound must be
released from the food matrix, whether by digestive enzymes or colonic microflora, and in the
right form to be absorbed before it can become bioaccessible (D'Archivio et al. 2007). The
caloric content and makeup of the food matrix can affect the bioaccessibility of digested
compounds. For example, an in vitro study showed that the bioavailability of isoflavones in food
was higher when consumed with fat and protein than compared to isoflavone supplements
consumed without food (Walsh et al. 2003). In a human study, researchers determined that
carotenoid bioavailability increased in human subjects when salads were consumed with full fat
and reduced fat salad dressing, but decreased when compared with consumption of salads with
fat free salad dressing (Brown et al. 2004). No absorption of carotenoids was observed when
salads with fat-free salad dressing was consumed, as carotenoids are fat-soluble compounds.
Overall, bioaccessibility is a crucial step to consider before assessing a compound’s
bioavailability. If a bioactive compound cannot be released from the food matrix in which it is
bound, it cannot be potentially bioavailable or susceptible to absorption through the gut barrier.
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Factors Affecting Bioavailability
As mentioned previously, the bioavailability of nutrients can be highly variable and
influenced by both exogenous factors (complexity of food matrix, molecular structure of
compounds) and endogenous factors (intestinal transit time, metabolism and extent of
conjugation) (Holst and Williamson 2008).
One particularly important endogenous factor to consider is the basic structure (molecular
size, degree of polymerization, solubility) of the bioactive compound, which determines the rate
and extent of intestinal absorption. For example, most polyphenols exist as esters, glycosides, or
polymers, but are not directly absorbable in their native forms. All flavonoids except flavanols
exist in glycosylated forms, consisting of one or more sugar moiety and an aglycone (Pandey and
Rizvi 2009). It is predicted that in order for passive diffusion of aglycones to occur across the
small intestine brush border, hydrolysis of the hydrophilic sugar moiety will likely be necessary
(Scalbert and Williamson 2000). The fate of glycosides is still unclear, but it is plausible that
most glycosides can resist acid hydrolysis in the stomach to arrive intact at the intestine, where
only aglycones and very few glycosides can be absorbed (Pandey and Rizvi 2009). Typically, the
sugar moieties in flavonoids consist of glucose or rhamnose, but can also be a number of other
sugars as well.
Glycoside activities can occur by way of enzymes such as β-glucosidase and lactasephlorizin hydrolase in the brush border of the small intestine, depending on the linked sugar
(Rein et al. 2013). However, if a flavonoid possesses a rhamnose moiety, absorption cannot
occur until the colonic microflora cleaves the sugar moiety from the aglycone (Rein et al. 2013).
The site of absorption of one polyphenol may be entirely different than another, as some
polyphenols are well absorbed in the small intestine, while others may not be absorbed until it
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reaches the colon or other parts of the gastrointestinal (GI) tract. Additionally, absorption can
depend on molecular weight, as in the case of oligomeric polyphenols and complex lipids. Due
to their high molecular weight, these compounds are unlikely to pass through intestinal epithelial
cells unless they are broken down first (Rein et al. 2013).
The metabolism and extent of conjugation for bioactive components also play a role in
their bioavailability. As the parent compound moves through the course of absorption, it may
also undergo extensive metabolism to increase solubility and facilitate excretion from the body.
Though the process of conjugation can produce active metabolites - such as those from some
dietary polyphenols - it can also decrease the total amount in the blood stream, thus decreasing
bioavailability (D'Archivio et al. 2007). In the case of most aglycones after absorption into
enterocytes, conjugation reactions create metabolites that are also substrates for transporters such
as multi drug resistance-associated protein 2 (MRP2) (Kanazawa 2011). Active excretion by
MRP2 effluxes the metabolite back into the digestive lumen. However, other transporters such as
MRP1 may play a role in transporting polyphenols into the bloodstream instead (Bohn 2014).
In the large intestine, bacteria may participate in the metabolism of polyphenols or the
resulting metabolites that have been re-excreted through enterohepatic circulation. Though
microbes may decrease the total amount of a parent compound, it has the potential to produce
active metabolites, as in the case of equol (Bohn 2014). Equol is a highly bioavailable metabolite
of daidzein, a bioactive compound found in soybeans, and has been shown to exhibit a stronger
estrogenic activity than daidzein (Ohtomo et al. 2008).
Bioavailability Studies of Bioactive Components
The main goal of bioavailability studies is to determine which bioactive food compounds
are the most well absorbed, which are the most active metabolites, and which lead to the
formation of active metabolites (D'Archivio et al. 2007). Categories of studies focusing on
14

bioavailability include in vitro methods such as cellular assays and in vivo models with animals
and human subjects, which are further subcategorized into epidemiological and intervention
studies (Biesalski et al. 2009).
In vitro models used in the assessment of the bioavailability of bioactive compounds
include simulated gastrointestinal digestion, artificial membranes, Caco-2 cell cultures and more.
Simulated gastrointestinal digestion, the most widely used in vitro method for assessing
bioaccessibility and bioavailability, typically consists of homogenization of the sample, lowering
the pH and adding pepsin to mirror that of gastric digestion, readjusting the pH and adding
pancreatic enzymes for the small intestine phase, followed by centrifugation to isolate desired
fractions (Carbonell-Capella et al. 2014). Advantages of this method include the ability to test
specific mechanisms of actions as well as the efficiency of each digestion, absorption, or
transport mechanism. Additionally, this method is relatively inexpensive and simple to use
(Carbonell-Capella et al. 2014). However, disadvantages also present barriers such as the
absence of homeostatic mechanisms and the inability to reproduce the dynamic conditions within
the GI tract that could otherwise be achieved in cell culture models (Carbonell-Capella et al.
2014).
Caco-2 cell culture assays consist of human colon epithelial cancer cell lines cultured as a
monolayer, usually on semipermeable plastic supports that fit into multi-well plates. In this way,
Caco-2 cells differentiate to form tight junctions that serve as a model for human intestinal
epithelial cells in the gut. Since oral administration is the most common route for the delivery of
food, the effectiveness of a compound to reach its intended site of action is dependent on
intestinal absorption. To test bioavailability, compounds of interest are added to the apical or
basolateral chambers and incubated. After a length of time, aliquots are taken from both sides
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and measured for the concentration of the compound (van Breemen and Li 2005). The rates of
permeability are then calculated to determine the apparent permeability coefficients (Papp) that
represent how readily a compound is absorbed from the lumen. The Caco-2 model is
advantageous for in vitro studies mainly due to the cell line’s ability to form into a monolayer
that closely mimics that of normal human intestinal epithelium, allowing researchers deeper
insight into the oral absorption of dietary compounds. However, there are still disadvantages in
regards to the Caco-2 model, including the absence of mucin, lack of cellular heterogeneity, and
the inability to study regional differences (Ingels and Augustijns 2003).
In animal studies, experiments are typically designed with rat and mice models using a
variety of methods, including in situ gastric administration, stomach intubation, Using chambers,
and the supplementation of bioactive compounds into control diets. Crespy and colleagues
(2002) observed that quercetin, but not its glycosides, is absorbed from the rat stomach through
an in situ gastric administration of quercetin, isoquercitrin (quercetin 3-O-glucose), and rutin
(quercetin 3-O-glucose-rhamnose) (Crespy et al. 2002). The methodology of flavonol
administration involved anesthetizing Wister rats before filling the stomach in situ with a mix of
6 mL buffer and 15 μmol/L of the selected bioactive compound, then collecting stomach
contents, bile, and blood samples for HPLC analysis. In another study, McGhie and colleagues
(2003) observed that anthocyanins from berry fruits (boysenberry, black raspberry and
blueberry) are absorbed and excreted largely unmetabolized, thus rendering low bioavailability
(McGhie et al. 2003). Five male subjects consumed 300 mL of water at 7:00 am on the morning
of the experiment, and an additional 300 mL of water was consumed every hr for the next 10 h.
At 10:00 am, blackcurrant, boysenberry, or blueberry extract (total volume of 300 mL) was
consumed instead. Each subject voided their bladder at every hr starting at 10:00 am until 4:00
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pm. The total amount of all anthocyanins excreted as a percentage of the administered dose was
less than 0.1%, confirming data from previous studies that the apparent bioavailability of
anthocyanins is considerably lower than for catechin or quercetin. Additionally, it was observed
that despite the high level of intersubject variation, anthocyanin absorption seems to be
influenced by chemical structure of both the sugar moiety and phenolic aglycone. For example,
bioavailability was apparently lower for delphinidin 3-O-glucoside (0.042%) and cyanidin 3-Oglucoside (0.040%) in comparison to delphinidin 3-O-rutinoside (0.067%) and cyanidin 3-Orutinoside (0.63%) (McGhie et al. 2003).
In human studies, the administration of bioactive compounds are through oral
consumption of a single dose provided as a pure compound, plant extract, whole food, or whole
beverage to healthy subjects. Like animal studies, the pharmacokinetics and extent of absorption
are typically analyzed by measuring plasma concentrations and/or urinary excretion. In a study
by Setchell and colleagues (2003) on the bioavailability, disposition, and dose-response effects
of soy isoflavones, 10 healthy women were given, on separate occasions, 10, 20 or 40 g of
toasted soy nuts to eat in a single bolus after an overnight fast (Setchell et al. 2003). This dosage
reflected increasing amounts of the conjugated forms of daidzein (6.6, 13.2 and 26.4 mg) and
genistein (9.8, 19.6 and 39.2 mg). Daidzein and genistein were absorbed quickly, reaching
maximum serum concentrations ranging from 2-8 h after ingestion. The bioavailability showed a
curvilinear relationship with increasing dosages of isoflavones ingested, showing reduced
systemic availability that is likely attributed to reduced absorption of isoflavones (Setchell et al.
2003). In another study on flavanone bioavailability in humans after ingestion of two doses of
orange juice, 5 healthy men were recruited to ingest 1 L then 0.5 L of orange juice on two
different days after an overnight fast, separated by a wash-out period of 15 days (Manach et al.
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2003). The juice contained 444 mg/L of hesperidin and 96 mg/L of narirutin. Researchers have
found that flavanone metabolites appeared in plasma 3 h after ingestion, with maximum
concentrations appearing between 5-7 h. The peak plasma concentration of hesperetin was 1.28
μmol/L, while naringenin was 0.20 μmol/L after the 1 L dose. Relative urinary excretion was
similar for the two compounds and did not depend on the dose: values ranged from 4.1% to 7.9%
of the intake. Since urinary elimination was almost complete after 24 h, it was suggested that
sustained effect of flavanones depend on a regular consumption of citrus fruits and related
products (Manach et al. 2003).
Berry Volatiles
The aroma of berries play a major role in its overall quality in fresh or processed fruits. In
the case of red raspberries, over 300 volatile compounds have been reported so far. Strawberries,
on the other hand, possess one of the most complex fruit aromas. There are approximately 350
volatile compounds present in strawberries, with furaneol and mesifurane as the more
dominating aroma compounds (Abbott et al. 2010). Esters make up over 90% of the total number
of volatiles in ripe strawberry fruit, while aldehydes and alcohols are responsible for the green,
unripe notes in strawberry aroma (El Hadi et al. 2013). Meanwhile, esters and alcohols make up
the top two most abundant volatiles in blackberries, with the sweet, fruity and green notes
attributed to volatiles such as terpinen-4-ol and 2-heptanol (Meret et al. 2011).
Limited research has been done on the bioavailability of specific purified berry volatiles
such as ethyl acetate, hexanal, α -terpinene, and terpinen-4-ol. It may be of interest to explore the
prospective health benefits of volatile and semi-volatile terpenic compounds as well as its
bioavailability through inhalation (Salvador et al. 2016). The concepts and mechanisms outlined
from studies on the bioavailability of volatile aromatic compounds, herbal medicinal products
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and essential oils may serve to further research on the bioavailability of berry volatiles. Herbal
medicinal products have long been used as a household remedy against colds, muscle aches, and
gastrointestinal disturbances. The efficacy of natural volatiles such as those contained in
essential oils is well-established for issues such as chronic pulmonary obstruction and acute
bronchitis (Kohlert et al. 2000). For example, clinical studies have been undertaken to evaluate
the efficacy of peppermint oil for the treatment of irritable bowel syndrome and tension-type
headaches (Kohlert et al. 2000). Essential oil components are usually administered through the
dermal, pulmonary, or oral routes (Kohlert et al. 2000). Monoterpenoid compounds such as
camphor, limonene and 3-carene are readily absorbed through dermal application due to their
lipophilic profile (Kohlert et al. 2000). Volatiles, particularly monoterpenes, are well suited to be
absorbed into the body via inhalation (Kohlert et al. 2000). The compounds may be absorbed by
the lung, in which case systemic availability could be possible (Kohlert et al. 2000). However,
factors such as the structure of compound and the breathing mechanics of subjects could
influence the degree of absorption during inhalation. Overall, the fate of essential oil components
in the body depend on their chemical structure. The major excretion pathway was through the
kidneys and lungs, with a minor pathway being fecal excretion (Kohlert et al. 2000). Due to their
volatility, essential oil components or their metabolites are likely to be exhaled (Kohlert et al.
2000).
In Vitro Studies
A study by Heinlein and colleagues (2014) investigated the permeability of hop aroma
compounds across Caco-2 monolayers, those of which included linalool (terpene alcohol found
in strawberries, blackberries, blueberries, red raspberries, black raspberries and cranberries),
nerol (monoterpene found in blackberries), and β-myrcene (monoterpene found in black
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raspberries) (Heinlein et al. 2014). Stock solutions of compounds in dimethylsulfoxide (DMSO)
were prepared, and diluted to a final concentration of 100 μM for each individually tested
compound. Nerol exhibited a high initial increase and the beginning of a steady-state after 80 –
100 min, while linalool showed a slower increase and an earlier steady-state after 60 min.
Permeability values for β-myrcene remained constant over time. The recovery percentages of
nerol, linalool, and β-myrcene were 58.8%, 25.6%, and 12.3%, respectively.
In Vivo Studies
Several in vivo studies of various berry volatiles have been untaken over the years,
including an animal study by Sporstøl and Scheline (1982) that observed the metabolism of
raspberry ketone – one of the main volatile compound in raspberries - in rats, guinea pigs and
rabbits. Animals were given intragastric dosages of 1 mmol/kg raspberry ketone, and it was
found that approximately 90% of the dose was recovered as metabolites in 0-24 h urines in all 3
species (Sporstøl and Scheline 1982). Additionally, urinary metabolite excretion was rapid and
nearly complete within 24 h. The most prominent urinary metabolites were raspberry ketone and
its corresponding carbinol, both conjugated through glucuronidation and/or sulfonation (Sporstøl
and Scheline 1982). Out of the three species, rabbits showed the greatest extent of ketone
reduction into carbinol due to the animal’s abundance of ketone reductases. Rats excreted the
highest number of metabolites, while guinea pigs showed the simplest pattern of metabolism. In
another animal study by Igimi and colleagues (1974), the absorption, distribution, and excretion
of d-limonene – a monoterpene found in many volatile oils as well as black raspberries – was
investigated. D-limonene was labeled with 14C and administered to 21 male Wistar rats (800
mg/kg) orally by stomach tube. D-limonene is absorbed rapidly from the GI tract during several
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hr, followed by rapid elimination with no significant accumulation in the body (Igimi et al.
1974).
Arachidin-1 and Arachidin-3
The prenylated stilbenoids arachidin-1 (Ara-1) and arachidin-3 (Ara-3) are bioactive
compounds derived from the root of peanuts (Arachis hypogaea). Both Ara-1 and Ara-3 are
derivatives of resveratrol, another stilbenoid compound that has been studied extensively for its
biological properties (Huang et al. 2010) (Figure 1). Ara-1 and Ara-3 have attracted the interest
of researchers in an effort to further investigate its diverse biological activities, especially its
antioxidant and anti-inflammatory effects. Ara-1 and Ara-3 exhibit higher degree of biological
activities such as antioxidant, anti-inflammatory, cardioprotective, antiviral and anticancer
properties in vitro with the potential in improving human health compared to resveratrol and
piceatannol, their nonprenylated analogues (Yang et al. 2015). Huang and colleagues (2010)
observed that Ara-1 induces programmed cell death in human leukemia HL-60 cells in a manner
that shows higher efficacy in comparison to resveratrol (Huang et al. 2010).
Resveratrol, along with quercetin, has been suggested to play a role in lowering the
prevalence of coronary heart disease among red wine drinkers, with potential mechanisms
including inhibition of LDL oxidation, platelet aggregation, and eicosanoid synthesis (Kaldas et
al. 2003). Studies have shown that certain human populations that consume a moderate amount
of red wine experience lower incidences of heart disease - this observation has since been
labelled “The French Paradox” (Abbott et al. 2010). Although resveratrol is known for its health
benefits, it has been reported to have low bioavailability in the body (Meng et al. 2004, Walle et
al. 2004). Meng and colleagues (2004) observed that more than 90% of resveratrol was
conjugated into other forms after 30 min of ingesting resveratrol. Resveratrol possesses limited
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oral bioavailability, consisting of rapid absorption and extensive metabolism, leading to the
production of various conjugated metabolites that could otherwise be responsible for its
biological effects (Yang et al. 2015).

Figure 1: Chemical structures of trans-resveratrol (1), trans-arachidin-1 (2), and trans-arachidin3 (3) (Adapted from Condori et al. 2010).
In Vitro Studies
Currently, bioavailability studies on Ara-1 and Ara-3 using the Caco-2 transport assay
have not yet been conducted. Most published research on the bioavailability of stilbenoids have
primarily focused on resveratrol. Because of resveratrol’s related chemical structure to that of
Ara-1 and Ara-3, estimations of the bioavailability of these two compounds can be made. A
study by Brents and colleagues (2012) found that Ara-1 and Ara-3 are metabolized to a lesser
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degree than its non-prenylated parent compounds, piceatannol and resveratrol. This suggests that
the lipophilic side chains of Ara-1 and Ara-3 may disrupt the glucuronidation process, thereby
enhancing the compounds’ bioavailability (Brents et al. 2012). Another study by Brents and
colleagues (2012) evaluated the activities of eight human UDP-glucuronosyltransferases (UGTs)
towards Ara-1, Ara-3, trans-piceatannol, and trans-resveratrol. The findings indicated that
prenylated stilbenoids may be preferable alternatives to trans-resveratrol due to its slower
metabolism. Since this occurs in response to in vitro metabolism by UGT isoforms found in the
liver and intestine, which are the main tissues responsible for metabolism of these compounds in
vivo, the results may be indicative of the same effects during human metabolism (Brents et al.
2012).
In Vivo Studies
Though in vivo bioavailability characteristics of Ara-1 and Ara-3 have yet to be
elucidated, studies on resveratrol within both animal and human models may serve to shed light
on the characteristics of its prenylated analogs. In the past, research has shown that resveratrol is
orally absorbed up to about 75% in humans, yet extensive metabolism in the intestine and liver
ultimately brings oral availability down to less than 1% (Walle 2011). An increased dosage and
repeated dose administration does not seem to alter availability significantly (Walle 2011). In a
study by Walle and colleagues (2004), 6 human subjects were administered single doses of
resveratrol orally (25 mg) and intravenously (0.2 mg). Cmax was reached at about 1 h after oral
ingestion of 491 ng/mL, with a second peak at 6 h after the dose of 290 ng/mL (Walle et al.
2004). The plasma concentrations then declined rapidly. After the intravenous dose, plasma
concentrations rapidly decreased in the first hr without any second peaks, unlike after oral
dosage (Walle et al. 2004). Despite this, only trace amounts of unchanged resveratrol (<5 ng/mL)
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could be detected in plasma, and most of the oral dose was recovered in urine (Walle et al.
2004). Rapid sulfate conjugation by the intestine and liver appears to be the rate-limiting step in
resveratrol’s bioavailability, thus leading to resveratrol’s low bioavailability (Walle et al. 2004).
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CHAPTER 3
Bioavailability of Bioactive Compounds in Peanuts
Abstract
Arachidin-1 (Ara-1) and arachidin-3 (Ara-3) have been shown to possess similar, if not
higher, efficacy in biological activities when compared to nonprenylated analogs such as
piceatannol and resveratrol (Resv). Although Resv is highly studied for its diverse biological
effects, it possesses extremely low bioavailability. The ability of a compound to exert its health
promoting effects depends on its bioavailable dose, rather than the administered dose. Therefore,
this study evaluates the stability of Ara-1 and Ara-3 under cell incubation conditions and
attempts to determine bioavailability using an in vitro Caco-2 transport assay. 100 - 200 ppm of
Resv (positive control), Ara-1, and Ara-3 were added separately to Caco-2 cells in
semipermeable inserts to evaluate absorption and transport. 0.5 mL aliquots were withdrawn at
various time points and analyzed using HPLC to determine rate of transport. Sample preparation,
extraction methods, and enzymatic treatments were adjusted to enhance recovery of Ara-1 and
Ara-3. However, Ara-1 was shown to be more susceptible to the effects of oxidation and
degradation, which may be attributed to its extra hydroxyl group, in comparison to Ara-3. At this
time, it is inconclusive whether Ara-1 and Ara-3 possesses higher bioavailability than its analog,
Resv, in cell incubation conditions due to little to no recovery during transport.
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Introduction
The prenylated stilbenoids arachidin-1 (Ara-1) and arachidin-3 (Ara-3) are bioactive
compounds derived from the root of peanuts (Arachis hypogaea). Both Ara-1 and Ara-3 are
analogs of resveratrol (Resv), a well-known stilbenoid that has been studied due to its diverse
biological properties (Huang et al. 2010). However, more recently, Ara-1 and Ara-3 have
attracted the interest of researchers who are interested in its health-promoting properties,
especially its antioxidant and anti-inflammatory effects. Ara-1 and Ara-3 exhibit higher degrees
of biological activities such as antioxidant, anti-inflammatory, cardioprotective, antiviral and
anticancer properties in vitro with the potential in improving human health in comparison to
Resv and piceatannol, their nonprenylated analogues (Yang et al. 2015).
Although Resv is widely studied, it has been reported to have low bioavailability in the
body due to extensive metabolism and rapid absorption (Meng et al. 2004, Walle et al. 2004,
Yang et al. 2015). Although bioavailability studies on Resv have been performed, no work has
been done on the bioavailability of Ara-1 and Ara-3 using Caco-2 transport assays. Previous
studies have noted that Ara-1 and Ara-3 may be less susceptible to extensive metabolism due to
the ability of lipophilic side chains to disrupt the glucuronidation process, thereby enhancing the
compounds’ bioavailability (Brents et al. 2012). Therefore, the objectives of this study were to 1)
evaluate the stability of Ara-1 and Ara-3 under incubation conditions using various sample
preparations, transport buffers and enzymatic treatments and 2) assess the bioavailability of Ara1 and Ara-3 by measuring their uptake and transport across the Caco-2 cell monolayer.
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Materials and Methods
Materials
Ara-1 and Ara-3 compounds were extracted from peanut hairy roots and generously
donated by Dr. Medina-Bolivar (Arkansas State University, Jonesboro, AR) following the
method of Abbott and colleagues (Abbott et al. 2010). Stock solutions were prepared by
solubilizing 1 mg each of dried Ara-1 and Ara-3 in 1 mL of ethanol. The stock solutions were
then divided into aliquots at known volumes, dried using nitrogen, and stored in amber glass
vials fitted with a cap at -20°C until ready for usage. Resveratrol was obtained from Tokyo
Chemical Industry (Philadelphia, PA). β-Glucuronidase from Helix pomatia, Type H-2 (>85,000
units/mL) was purchased from Sigma Aldrich (St. Louis, MO). All media components and
reagents were obtained from Gibco® through ThermoFisher (Grand Island, NY).
Optimizing Separation of Ara-1, Ara-3 and Resveratrol using HPLC
Quantitative analysis of Ara-1, Ara-3 and Resv (control) was performed using the
modified method of Yang and colleagues (Yang et al. 2016). Samples were analyzed using a
System Gold HPLC system (Beckman-Coulter, Fullerton, CA, USA) equipped with a model 126
dual pump, a model 508 autosampler, and a model 168 photodiode array detector with BeckmanCoulter System 32 Karat software (Version 8, 2006). Separation was carried out using a 4.6 mm
× 250 mm Aqua 5 µM C18 column (Phenomenex) with flow rate at 1 mL/min. The mobile phases
consisted of 2% formic acid in water (A) and 100% methanol (B). The gradient system was
modified to optimize separation as follows: initial equilibration with 50% B for 2 min , increase
from 50-65% B over 30 min , held at 65% B for 2 min , increase from 65-100% B over 5 min
before returning to the initial binary gradient of 50% B. The injection volume was 50 μL. UVvisible spectra was monitored at 340 nm for Ara-1, Ara-3 and Resv.
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Detection Limit of Ara-1 using HPLC
In addition to using HPLC to quantitate recovery of the compounds throughout the
transport assay, the method was also used to determine the detection limit of Ara-1. This
parameter was investigated for two reasons: (1) a low response of Ara-1 was observed in
comparison to Resv and Ara-3 despite analyzing all three compounds at the same concentration
and (2) the detection limit informs the necessary concentrations of Ara-1 required for the
treatment in anticipation of multiple dilution factors during the transport assay. To begin, 50 uL
of Ara-1 (1 mg/mL) in ethanol was evaporated to dryness with nitrogen and redissolved in 1 uL
DMSO in a 13 x 100 mm borosilicate glass culture tube. The mixture sonicated for 1 min and
vortexed for 10 sec with 638 uL of working Dulbecco’s modified Eagle’s Medium (WMEM) to
create a standard curve using 1:4 serial dilution in WMEM. Finally, the samples were passed
through a 13 mm, 0.45 um PTFE syringe filter into HPLC vials for immediate analysis.
Concentrations of Ara-1 and Ara-3 were determined using a standard curve of each compound
with concentration ranging from 0.624 ppm to 78 ppm.
UPLC Tandem Mass Spectroscopy (UPLC-MS/MS) Analysis
Liquid chromatography-mass spectrometry qualitative analysis of Ara-1 and Ara-3 was
performed using the modified method of Yang and colleagues to confirm characterization after
extraction and purification of the compounds from peanut hairy roots (Yang et al. 2016). A
Shimadzu 8040 UPLC system was used for the chromatographic separation. The separation
method was similar to the conditions described above with the following modification: water
was used in mobile phase A and 0.1% formic acid in acetonitrile was used in mobile phase B.
UPLC-MS/MS analysis was conducted using a Shimadzu 8040 triple quadrupole liquid
chromatograph mass spectrometer with an electrospray ionization source to obtain structural
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information of Ara-1 and Ara-3 after initial purification. The separation was performed on a 2.1
× 50 mm 1.9 µM C18 column with a flow rate at 0.2 mL/min. A linear gradient was performed
from 30-80% B over 8 min. Briefly, all mass spectra were performed in the positive ion mode
with an ion spray voltage at 4 kV, sheath gas (high-purity nitrogen) at 45 arbitrary units,
auxiliary gas (high-purity nitrogen) at 15 arbitrary units, capillary voltage at 9 V, capillary
temperature at 300°C and tube lens offset at 45 V. Full mass scans were recorded in the range
m/z 100 to 2,000. Ultra-high-purity helium was used as the collision gas, and 35% collision
energy was applied in collision-induced dissociation.
Cell Culture Maintenance
Caco-2 human colon cancer cells were purchased from the American Type Culture
Collection (ATCC, Rockville, MD, USA) at passage number 18. Cells were cultured according
to the protocol of Salyer and colleagues (Salyer et al. 2013) in Dulbecco’s modified eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% non-essential amino
acids, 2% antibiotic-antimicotic, and incubated at 37 °C.
Preparation of Cell Monolayers for Transport Assay
At 80-90% confluency, Caco-2 cells were trypsinized and seeded onto Transwell inserts
(polycarbonate membrane, 12 mm i.d., 0.4 μm pore size, Corning Inc., Kennebunk, ME) in 12well plates at a density of 1.0 × 105 cells/cm2.
The seeded Transwell inserts were treated with 500 uL and 1500 uL of WMEM on the
apical and basolateral side, respectively. Cells were allowed to grow and differentiate to form a
monolayer for 14-21 days post-seeding. The growing medium were replaced at days 3, 5, and
daily thereafter. Transepithelial electrical resistance (TEER) of cells grown in the Transwell
were measured using the Millicell ERS-2 voltohmmeter (Millipore Corp., Billerica, MA, USA)
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to ensure cell monolayer integrity. Only monolayers with TEER values >400 Ωcm2 were used
for further experimentation. Only passages 25-40 were used in this assay since a defined interval
of passages is recommended to ensure a consistent cellular phenotype in all experiments.
Transport Assay
On the day of the assay, dried Ara-1 and Ara-3 was first solubilized in DMSO and mixed
with a vortex mixer for 1 min. The solution was then diluted in a 15 mL centrifuge tube with
WMEM warmed to 37°C to a final concentration of 78 and 74 ppm, respectively, and sonicated
for 1 min. The final test solution contained 0.1% DMSO.
Prior to each assay, WMEM in both chambers was aspirated and 500 uL of the treatment
were added to the apical chamber in duplicate. Meanwhile, 1 mL of phosphate-buffer solution
(PBS) was added to the basolateral chamber.
To start the experiment, the system was incubated at 37 °C for 2 h. 500 uL samples were
drawn from the basolateral chamber at 0, 0.5, 1 and 2 h. The samples were mixed with 25 uL of
trifluoroacetic acid (TFA) and 25 uL of 70% ethanol and frozen immediately. The basolateral
chamber was replenished with 500 uL of PBS at each time point. At 2 h, remaining solutions in
both chambers were collected. The apical and basolateral chambers were then washed with 1.5
mL and 1 mL of PBS, respectively, mixed with 25 uL of TFA and 25 uL of 70% ethanol and
pooled with the samples drawn at the 2 h time point. The stock solution as well as aliquots drawn
from the apical chamber at the end of the experiment were used to calculate mass balance.
The insert membrane was carefully peeled off with a tweezer, placed into a 1.5 mL
microcentrifuge tube with 100 uL of cold MQ water, 10 uL of TFA and 10 uL 70% ethanol, then
vortexed vigorously for 10 s to solubilize cells from the membrane. All aliquots and cell
membrane suspensions were frozen at -20°C until further analysis.
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Preliminary HPLC analysis prior to experimentation showed that background peaks from
WMEM and PBS – two liquid components in the transport assay system – did not interfere or
coelute with peaks from Resv, Ara-1 and Ara-3. Based on this observation, all collected samples
were directly injected into the HPLC for analysis using the following procedure: samples were
thawed to room temperature, sonicated for 10 min and vortexed for 10 sec. 190 uL was
withdrawn and was treated with 10 uL of 20 ppm Resv in DMSO as an internal standard. The
mixture was then vortexed once more and passed through a 0.45 μm, 4mm polyethersulfone
(PES) filter prior to HPLC injection. PES filters were used to replace PTFE filters used in prior
filtration due to low protein binding, hydrophilicity, and faster flow rates.
Transport Assay with 200ppm Ara-1 and Ara-3
Under the newly altered experimental conditions, the preparation of samples did not
change except for the concentration of Ara-1 and Ara-3. 200 ppm of Ara-1 and Ara-3 were used
as treatment solutions.
The samples collected were additionally subjected to solid phase extraction (SPE) in
hopes of concentrating Ara-1 and Ara-3 recovery and eliminating other possible interfering
compounds. First, Sep-Pak C18 classic 260 mg sorbent cartridges were preconditioned with 2 mL
of DI water and 2 mL of 100% methanol. Then, 475 uL of thawed samples were spiked with
Resv as an internal standard for a final concentration of 1 ppm. Next, 0.5 mL aliquots of the
solution were loaded onto the preconditioned cartridges and eluted for cleanup with 1.5 mL of
5% MeOH in 0.5 mL increments. After drying the cartridge, Ara-1 and Ara-3 were eluted with 1
mL of 100% methanol. The eluates were vortexed for 1 min and passed through a 13mm, 0.45
μm PTFE syringe filter for immediate HPLC analysis.
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Extended Transport Assay with 200ppm Ara-1 and Ara-3
To rule out if Ara-1 and Ara-3 simply took longer than 2 h to transport to the basolateral
chamber, the transport assay was extended to 4 h. The concentration was kept constant at 200
ppm for both compounds. Meanwhile, additional modifications were made: the aliquots collected
from the basolateral chamber at each time point were mixed with 100 uL of methanol instead of
TFA and 70% ethanol. The insert membranes were treated with 0.5 mL of ice-cold MQ water,
rinsed with the same volume of water between samples and vortexed vigorously with 0.5 uL 1 N
NaOH for 10 s to solubilize cells from the membrane. All aliquots and cell membrane
suspensions were frozen at -20°C until further analysis.
All collected samples were thawed to room temperature, sonicated for 10 min and
vortexed for 10 sec. 190 uL was withdrawn and was treated with 10 uL of 20 ppm Resv in
DMSO as an internal standard. The mixture was then vortexed once more and passed through a
0.45 μm, 4mm polyethersulfone (PES) filter prior to HPLC injection.
To evaluate if Ara-1 and Ara-3 may have been sequestered within the Caco-2 cells during
transport, previously frozen cell culture inserts were thawed to room temperature and centrifuged
at 13000 rpm for 10 min. The supernatant was transferred into a borosilicate disposable test tube,
mixed with 300 uL methanol, vortexed for 1 min, and centrifuged again at 13000 rpm for 10
min. The supernatant was collected in the first test tube. Once again, the cell membrane was
mixed with 300 uL methanol, vortexed for 1 min, and centrifuged at 13000 rpm for 15 min. The
supernatant was collected, and 2 mL of DI water was added. The solution was loaded into a
preconditioned Sep-Pak C18 cartridge, cleaned up with 3 mL of 5% methanol, and air dried.
Compounds of interested were eluted with 1 mL of methanol. The eluate was dried under
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nitrogen, reconstituted with 200 uL 100% methanol and passed through a 0.45 μm PTFE syringe
filter for immediate HPLC analysis.
Time Course Changes in pH of WMEM and PBS under Experimental Conditions
To gather more information on whether pH influenced the stability of Ara-1 and Ara-3
under experimental conditions, a time course of pH change was performed for both WMEM and
PBS. To begin, 4 mL of either PBS or WMEM were warmed at 37°C and divided evenly into
two empty wells in a 12-well plate. This was done because the total volume needed for the time
course surpassed the volume that each well could hold. The plates were incubated for 4 hr, in
accordance to the length of the transport assay, at 37°C with 5% CO2 to resemble experimental
conditions. 500 uL aliquots were taken at time points 0, 1, 2, 3 and 4 h and the pH immediately
read with a pH meter.
Time Course Changes in Stability of Ara-1 and Ara-3 in WMEM and PBS under
Experimental Conditions
According to the time course on changes in pH of WMEM under experimental
conditions, the experiment was rerun in the same manner except for the following modifications:
Ara-1, Ara-3 and Resv was mixed with either WMEM or PBS to a final concentration of 200
ppm and 0.1% DMSO. The duration of the time course was also reduced to 3 h instead of 4 h.
Approximately 200 uL was taken as an aliquot and passed through a 0.45 μm, 4 mm PES filter
immediately for HPLC analysis.
The purpose of this time course was to compare the stability of the compounds in each
aqueous solution to determine whether the transport media needs to be changed. Resv was
included because of its role as a positive control in future transport assay.
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Transport Assay with Modified Transport Buffer
The time course experiments ran previously shows that WMEM may still be a viable
transport buffer for Ara-1 and Resv, but not Ara-3. This time, two different transport buffers
were used in the assay: 1) WMEM without FBS to prevent the likelihood that the compounds
would bind to proteins in the serum and form a complex too large for HPLC detection and 2)
PBS.
On the day of the assay, dried Ara-1 and Ara-3 was first solubilized in DMSO and mixed
with a vortex mixer for 1 min. The solution was then diluted separately in a 15 mL centrifuge
tube with the previously mentioned transport buffers, warmed to 37°C to a final concentration of
100 ppm and sonicated for 1 min. The final test solutions contained 0.1% DMSO.
Prior to each assay, WMEM in both chambers was aspirated and 500 uL of the two
separate treatments were added to the apical chamber in duplicate. Meanwhile, 1 mL of PBS was
added to the basolateral chamber.
To start the experiment, the system was incubated at 37 °C for 3 h. A 500 uL aliquot was
collected from the basolateral chamber at each time point and mixed with 100 uL of methanol.
The insert membranes were treated with 0.5 mL of ice-cold MQ water, rinsed with the same
volume of water between samples and vortexed vigorously with 0.5 uL 1 N NaOH for 10 s to
solubilize cells from the membrane. All aliquots and cell membrane suspensions were frozen at 20°C until further analysis.
At time of HPLC analysis, all samples were thawed to room temperature, sonicated for
10 min and vortexed for 10 sec. 190 uL was withdrawn and was treated with 10 uL of 20 ppm
Resv in DMSO as an internal standard. The mixture was then vortexed once more and passed
through a 0.45 μm, 4mm PES filter prior to HPLC injection.

40

Transport Assay with HBSS and Enzymatic Treatment
To further elucidate the behavior of Ara-1 and Ara-3 under experimental conditions, the
method was modified to include enzymatic treatment of the samples following collection by βglucuronidase and sulfatase. If the compounds are undergoing glucuronidation or sulfonated due
to metabolic processes in the Caco-2 cells, the enzymes may free the parent compound from its
conjugate. Doing so could allow for the HPLC detection of Ara-1 and Ara-3 in its unconjugated
form.
The methodology was the same as described in the previous section with the following
modifications: Ara-1 and Ara-3 were prepared using Hank’s Balanced Salt Solution (HBSS) with
a final concentration of 0.1% DMSO. HBSS was chosen because of its role in maintaining pH,
osmotic balance, and cell signaling without potential interference from ingredients of WMEM.
Prior to each assay, WMEM both chambers was aspirated and 500 uL of the treatment were
added to the apical chamber in duplicate. Meanwhile, 1 mL of HBSS was added to the
basolateral chamber.
To start the experiment, the system was incubated at 37 °C for 3 h. A 500 uL aliquot was
collected from the basolateral chamber from time point 0 to 2 h. At time point 3 h, approximately
400 uL of HBSS was collected from the apical chamber, while approximately 900 uL of HBSS
was collected from the basolateral chamber. The apical chamber was rinsed with 0.5 or 0.6 mL
of HBSS two times for a final collected volume of 1 mL in both the apical and basolateral
chamber. The insert membranes were treated in the same way as described in the previous
section. All aliquots and cell membrane suspensions were frozen at -20°C until further analysis.
Enzymatic treatment for time point 0 h aliquots were allowed to thaw to room
temperature and mixed with 2 mL of ethyl acetate. The mixture was vigorously vortexed for 1
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min, and then centrifuged at 3000×g at room temperature for 10 min. The supernatant was
collected in a borosilicate disposable test tube, dried using nitrogen, reconstituted in 250 uL of
MeOH, and passed through a 0.45 μm PTFE filter for immediate HPLC analysis.
For the enzymatic treatment of other time points, aliquots were thawed to room
temperature, spiked with Resv as an internal standard to a final concentration of 1 ppm, then
mixed with 0.5 mL sodium acetate buffer (0.2 M, pH 5.0) and 10 uL of β-glucuronidase sulfatase
(H2 type). The samples were incubated for 20 h at 37°C in a water bath and agitated periodically
to potentiate enzyme activity. After 20 h, the samples were removed from incubation and mixed
with 2 mL of ethyl acetate, vigorously vortexed for 1 min, centrifuged at 3000×g at room
temperature for 10 min. The supernatant was collected in a borosilicate disposable test tube,
dried using nitrogen, reconstituted in 250 uL of MeOH, and passed through a 0.45 μm PTFE
filter for immediate HPLC analysis.
Enzymatic treatment of insert membranes was as follows: 1.5 mL of sodium acetate
buffer (0.2 M, pH 5.0) and 30 uL of β-glucuronidase sulfatase (H2 type) were added to thawed
insert membrane samples. Resv was added for a final concentration of 1 ppm as an internal
standard. The samples were incubated for 20 h at 37°C in a water bath and agitated periodically
to potentiate enzyme activity. After 20 h, they were removed and transferred to a 15 mL
centrifuge tube, mixed with 4 mL of ethyl acetate, and subjected to the same protocol as time
points 1 and 2 as described above.
Enzymatic treatment of HBSS was as follows: approximately 0.4 mL of sodium acetate
buffer (0.2 M, pH 5.0) and 8 uL of β-glucuronidase sulfatase (H2 type) were added to thawed
solutions. Resv was added for a final concentration of 1 ppm as an internal standard. Incubation
times and subsequent steps were the same as described above.
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Apical Time course Experiment of Ara-1 and Ara-3
In a final attempt to examine the fate of Ara-1 and Ara-3 in the apical layer in real time
under experimental conditions with Caco-2 cells, the method was modified to include alkali
treatment either with or without enzymatic treatment of only apical samples following collection
by β-glucuronidase and sulfatase as previously described above. Alkali treatment was attempted
to elicit cleavage of potential dimers or polymers of Ara-1 and Ara-3 that may have formed in
the apical chamber.
The methodology was the same as described in the previous section in terms of
preparation for the assay with the following modification: 100 ppm of Ara-1 was solubilized in
HBSS and 0.1% DMSO, while DMEM was used as the transport buffer for Ara-3 (since
solubility was problematic in PBS) with the same concentration of DMSO. 4 wells each in a 12
well plate were used to track Ara-1 and Ara-3 separately throughout the time course experiment.
The contents in the apical chamber of the first wells were collected for time point 1 h, as it was
assumed that nothing transported at time point 0 h. The second wells were for time point 2 h,
third wells for time point 3 h to be subjected to alkali treatment without enzymatic treatment, and
the fourth wells for time point 3 h to be subjected to both alkali and enzymatic treatment.
The original treatment solutions as well as time point 1 h and 2 h were directly injected
for HPLC analysis after being passed through a 0.45 μm, 4 mm PES filter.
Time point 3 h samples without enzymatic treatment were prepared in the following
manner: 1 mL of alkali treatment (2 N NaOH, pH 6-7) was mixed with the thawed samples and
heated at 60°C for 15 min. After cooling to room temperature, 1.5 mL of ethyl acetate was
added, vortexed vigorously for 1-2 min, and centrifuged at 3000 rpm for 10 min. The mixture

43

was dried under nitrogen, reconstituted in 250 uL of MeOH, and filtered through a 0.45 μm
PTFE filter for immediate HPLC analysis.
Time point 3 h samples with enzymatic treatment were prepared in the same manner,
except with 20 uL of β-glucuronidase sulfatase (H2 type) added after pH of the alkali-treated
sample was adjusted to pH 5 with HCl. The samples were incubated at 37°C for 20 h. After
incubation, the samples were mixed with 2 mL of ethyl acetate, vigorously vortexed for 2 min,
dried under nitrogen, reconstituted in 250 uL of methanol, and filtered through a 0.45 μm PTFE
filter for immediate HPLC analysis.
Statistical Analysis
All statistical analyses will be performed using Statistical Analysis Software (System
Version 9.4; SAS Institute Inc., Cary, NC) using a one-way analysis of variance test (ANOVA).
Data will be expressed as means + standard error of mean (SEM). A difference of p<0.05 will be
considered significant.
Results
Optimizing Separation of Ara-1, Ara-3 and Resveratrol using HPLC
The chromatogram of Ara-1, Ara-3 and Resv in WMEM is shown in Figure 1. The
compounds were solubilized in WMEM with a final concentration of 0.1% DMSO because it
was important to determine if separation was possible if samples from the transport assay were to
be directly injected into the HPLC, since WMEM is the transport buffer. The figure shows that
the background peaks stemming from WMEM are close to, but do not interfere with the elution
of Resv at 5.2 min. Ara-1 elutes second around 10.6 min, and Ara-3 elutes last at 13.6 min due to
its nonpolar structure.
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UPLC Tandem Mass Spectroscopy (UPLC-MS/MS) Analysis
The UPLC-MS/MS spectra of Ara-1 and Ara-3 is shown in Figure 2, which was
performed to verify the structure of the compounds after extraction. According to Yang and
colleagues, the MS/MS fragments for Ara-1 were listed as m/z 313 --> 257, 239, 229, 211 and
Ara-1 as m/z 297 --> 241, 223, 213, 195, which is consistent with the results shown (2016).
Transport Assay
Samples collected from time point 0 h were screened using HPLC to determine if Ara-1
and Ara-3 were transporting immediately after being applied to the cells, which may be
indicative of a faulty monolayer and/or incomplete tight junctions between Caco-2 cells. No
compounds were detected in the basolateral chamber at this time point.
At time point 0.5 and 1 h, neither Ara-1 nor Ara-3 were detected in the basolateral
chamber. This is unusual, as a previous transport study of Resv by intestinal Caco-2 cells
performed showed that the highest concentration (40 μM of Resv) yielded a detectable response
of 2000 pmol mL-1 in the basolateral chamber at time point 1 h (Kaldas et al. 2003). Granted,
Resv is slightly different in structure by the addition of a prenylated group and extra hydroxyl
group in Ara-1 and an extra hydroxyl group in Ara-3. There was no basis or prior literature to
compare transport data to for Ara-1 and Ara-3, so it was assumed that perhaps a higher
concentration was needed to increase peak response, given that the transport system works but
the concentration of the transported compounds was still below detection level.
Another noteworthy observation is that the standard curve made from the same stock
solution of Ara-1 and Ara-3 in WMEM became increasingly unreliable due to decreased peak
response and possible deterioration of the compounds in refrigerated storage. A difference of the
stock solution before and after 7 days in storage is shown in for Ara-1 in Figure 3 and Ara-3 in
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Figure 4. Ara-3 showed a decrease of 35.2% in peak area after 7 days, while Ara-1 showed a
much sharper decrease of 64.7%.
Additionally, the presence of minor peaks was also evident before and after storage –
several increased, while others decreased. The numbers in the chromatogram correspond to
notable increases or decreases in possible oxidation products or other unidentified byproducts.
For example, Peak 2 area (figure 3) increased by 12.1% while lambda max changed from 267 nm
to 266 nm. Peak 3 area, on the other hand, decreased by 49.4% while the lambda max remained
the same. Minor peak formation was not as prominent in Ara-3 before and after storage (figure
4); however, a stark increase was shown in Peak 2 with an increase by 251.9% in area. The
lambda max interestingly changed from 279 nm to 325 nm, indicating either an inaccurate
lambda max due to low response, instrumental variability, co-elution, or the formation of a
different compound altogether.
Overall, altered experimental conditions were implemented to elucidate whether the lack
of transport seen in Ara-1 and Ara-3 were due to: instability of the compounds under
experimental conditions (e.g. effects of pH, possible oxidation, complexation in WMEM),
extended transport time beyond 2 h of experiment, accumulation of Ara-1 and Ara-3 within
Caco-2 cells, flaw in the transport system itself, and/or lack of equipment sensitivity.
Transport Assay with 200ppm Ara-1 and Ara-3
Increasing the concentration of Ara-1 and Ara-3 from 74 ppm and 78 ppm, respectively,
to 200 ppm of each did not considerably increase peak response as previously thought. There
were also issues regarding the standard curves of Ara-1 in WMEM. HPLC analysis showed that
responses ranging 0.5 ppm to 200 ppm fluctuated and therefore did not yield a linear response.
However, Ara-3 maintained linearity and did not seem to have issues. Ara-3 showed peaks with
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the same retention time (RT) as Ara-1 in several wells at time points throughout the transport
assay, but the lambda max was 263 nm instead of 340 nm. This variability could be due to
factors such as instrument variability and too low of a response; nonetheless, the compound
could not be confirmed given the information available. Even if the compound in question was
Ara-1, the standard curve cannot be used to quantitate the amount transported due to its
unreliability.
Incorporating SPE as a final step to extract Ara-1 and Ara-3 did not seem to have an
effect. No peaks were detected except that of Resv as the internal standard, indicating that the
extraction method was effective at recovering similarly nonpolar compounds. In this regard, it is
assumed that the absence of Ara-1 and Ara-3 after SPE indicates that little to none of the
compounds transported to the basolateral chamber.
Extended Transport Assay with 200ppm Ara-1 and Ara-3
The length of the experiment was modified from 2 h to 4 h in the event that Ara-1 and
Ara-3 took longer than 2 h to transport across the monolayer. However, neither Ara-1 nor Ara-3
were detected in the basolateral chamber throughout all time points, evidencing that their
absence was likely not due to extensive transport rates. The compounds are being affected
somehow either before they managed to cross into the basolateral chamber, or they were
accumulating inside the Caco-2 cells.
Additionally, the treatment solutions of Ara-1 and Ara-3, prepared immediately prior to
experimentation, were analyzed on the HPLC immediately after preparation for mass balance
purposes. In comparison to the apical layer at the end of the 4 h time point, both compounds’
areas had diminished by approximately 99.99% ± 0.00% and 96.45% ± 0.25%, respectively.
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To confirm whether the compounds were sequestered inside the cells, insert membranes
were lysed and the contents repeatedly extracted to elute the Ara-1 and Ara-3 through SPE. Once
again, Resv as an internal standard consistently appeared in all the samples, indicating that the
extraction method was successful. However, no responses from the corresponding peaks
associated with Ara-1 and Ara-3 were observed, which further suggests that little to none of the
compounds were caught in the monolayer. Since the recovery of Ara-1 and Ara-3 in the apical
layer was extremely low, this suggests that the compounds have either degraded in the solution
they were solubilized in (WMEM) before transport occurred, or they have undergone structural
changes that eludes HPLC detection (perhaps high molecular weight products of dimerization or
degradation products).
Perhaps the most noteworthy finding was observed after removing the original treatment
solution used for this modified experiment from the refrigerator 7 days later. A distinct color
change between Ara-1 and Ara-3 in WMEM occurred in storage after unwrapping the foil used
to protect the light-sensitive compounds, as shown in Figure 5. On the left (Fig.5-A), Ara-1
changed from a bright pink color to that of a dark red, while Ara-3 (Fig. 5-B) remained
unchanged. The right (Fig. 5-C) is plain WMEM stored at 5 °C for the same amount of time.
Typically, polyphenols experience browning due to oxidation and/or polymerization, which
could explain why Ara-1 displayed inconsistent peak responses and had decreased in area after
refrigerated storage – even before experimentation or contact with Caco-2 cells. It may be
undergoing oxidation, serum binding, biotransformation, polymerization or another reaction that
causes deterioration of the parent compound and the production of new compounds, which could
also explain the prevalence of minor peaks when compared to Ara-3.
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Time Course Changes in pH of WMEM under Experimental Conditions
Figure 6 shows that PBS, with an expected pH of 7.4, decreased at 1 h to approximately
pH 6.5. On the other hand, WMEM was higher than expected at approximately pH 8. The two
time courses were performed separately, but perhaps the two systems work together at
physiological pH to buffer changes during the transport assay. Nonetheless, the high pH of
WMEM alone is worrisome given that Resv was previously shown to be unstable in a 50 mM
phosphate buffer (pH 8.0) at 37°C, leading to degradation within a matter of hr (Zupančič et al.
2015).
Time Course Changes in Stability of Ara-1, Ara-3 and Resv in WMEM and PBS under
Experimental Conditions
Data regarding the stability of Ara-1 and Resv in both WMEM and PBS could be
gathered, but the recovery of Ara-3 in PBS proved to be extremely difficult. The area of Ara-3 in
WMEM did not seem to diminish; in fact, recovery was about 97.0% ± 0.2% at 3 h. However,
when the same experiment was conducted with PBS, Ara-3 was barely detected at time point 0 h
and beyond despite multiple attempts, close attention to pipetting technique, and carefully
solubilizing the compound in PBS. To determine if the issue had to do with the instrument itself,
other samples with known concentrations were analyzed with no issues. To determine if PBS
was the issue, a 0.1 mg of Ara-3 was dissolved in 1 mL of 80% methanol. Ara-3 showed a strong
response in this corresponding chromatogram – suggesting that the strange results observed
previously was not an instrumental error. Normally, one would assume that Ara-3 simply is not
solubilized well in PBS. However, dissolving Ara-3 in DMSO and PBS was performed in the
past and analyzed using HPLC with no issues. The peak response was not as high as WMEM,
but detectable nonetheless.
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The end of the 3 h time course showed that Ara-1 had 77% ± 4.11% and 96.1% ± 11.56%
recovery in WMEM and PBS, respectively (Figure 7). On the other hand, Resv had 109.6% ±
8.0% in WMEM and 114.8% ± 13.5% in PBS at the end of 3 h (Figure 8). The higher recovery
in Resv could be attributed to inaccurate pipetting or insufficient solubility in the beginning of
the experiment. There were no significant differences between WMEM and PBS as transport
buffers in the recovery of Ara-1 or Resv at each time point.
Overall, it appears that even though there was no significant difference, Ara-1 may be
more susceptible to degradation in WMEM compared to PBS. The recovery of Resv in WMEM
and PBS were very comparable. A comparison of Ara-3 in WMEM and PBS was not possible;
however, data has shown that WMEM could still be a viable transport buffer.
Transport Assay with Modified Transport Buffer
Despite eliminating FBS (fetal bovine serum) in the WMEM transport buffer, HPLC
analysis shows that neither Ara-1 nor Ara-3 were detectable throughout the experiment in the
basolateral chamber, but Resv (control) was detected in both the apical and basolateral chamber.
This suggests that the issue of recovery regarding Ara-1 and Ara-3 was likely not due to protein
binding in the presence of FBS.
PBS was used as an alternate transport buffer to simplify the transport assay system and
to prevent the complex ingredient profile from interfering with the recovery of Ara-1 and Ara-3.
The attempt was also another chance to verify whether the stock of Ara-3 used previously in the
time course experiment was indeed contaminated or problematic. Once again, neither Ara-1 nor
Ara-3 were detectable in the basolateral chamber. Additionally, only 0.13% ± 0.03% of Ara-1
remained in the apical chamber at time point 3 h out of the amount originally applied at time
point 0 h. Ara-3 was not detected at time point 0 h or 3 h at all. On the other hand, 10.23% ±
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0.49% of Resv remained in the apical chamber, while none was recovered in the basolateral
chamber, likely due to solubility issues in during preparation.
Transport Assay with HBSS and Enzymatic Treatment
To further elucidate the behavior of Ara-1 and Ara-3 under experimental conditions, the
method was modified to include enzymatic treatment of the samples following collection by βglucuronidase and sulfatase. Unfortunately, the compounds did not seem to be undergoing
glucuronidation or sulfonation due to metabolic processes in the Caco-2 cells because the parent
compounds of Ara-1 or Ara-3 were not detected in the basolateral chamber using HPLC analysis
throughout the duration of the transport assay. Another reason could be that theyw ere
polymerized or complexed similarly as the parent compound.
The insert membranes of Ara-1 and Ara-3 were subjected to enzymatic treatment to yield
potential parent compounds that may have been metabolized within the cell. After analysis, it is
observed that Resv consistently appeared as an internal standard, but responses from Ara-1 and
Ara-3 could not be observed according to inconsistent retention time and lambda max.
Apical Time course Experiment of Ara-1 and Ara-3
Finally, the fate of Ara-1 and Ara-3 in the apical layer was observed in real time under
experimental conditions with Caco-2 cells using alkali treatment of apical samples either with or
without enzymatic treatment of. Subjecting samples to alkaline conditions were performed to
elicit cleavage of potential dimers or polymers of Ara-1 and Ara-3 that may have formed in the
apical chamber. This was previously difficult to test because withdrawing aliquots during the
transport assay in the presence of cells meant that the well could no longer be used - this is
because the volume of aliquot necessary for analysis meant that the treatment solution
(approximately 0.5 mL) in the apical chamber must be completely withdrawn. Even if this were
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not the case, any volume taken from the apical chamber would interfere with mass balance at the
end of the transport assay. Lastly, the preservation of limited quantities of Ara-1 and Ara-3 as
well the length of time needed for monolayer formation were other reasons why this time course
experiment was not attempted previously.
At time point 1 h, Ara-1 in HBSS decreased to 37.9% of the original area after HPLC
analysis. At time point 2 h, no Ara-1 was detected at all. Ara-1 was not detected at time point 3 h
after alkali treatment with or without enzymatic treatment. The results strongly suggest that the
stability of Ara-1 is related to the presence of Caco-2 cells, as the previous time course
experiment of Ara-1 in WMEM and PBS without Caco-2 cells yielded 104.1% ± 4.8% and
100.8% ± 9.6% recovery at time point 1 h. Though the transport buffers used were different, one
can predict that the responses of PBS and HBSS would be similar.
The original area of Ara-3 could not be determined because HPLC analysis showed no
response at all. As a result, a comparison could not be made between all other time points,
regardless of alkali treatment or enzymatic treatment, since the original treatment did not contain
Ara-3 for an unknown reason. The treatment solution could have very well contained Ara-3, but
the amount remained undetected by HPLC. Originally, it was thought that Ara-3 was not soluble
in PBS, but it appears that Ara-3 has been affected somehow during storage or preparation in
such a way that prompts little to no response even in DMEM during HPLC analysis.
Discussion
For a long time, Resv has been known to possess a wide range of purported health
benefits, including anti-inflammatory, antioxidant, and anti-cancer activities. Despite the diverse
biological activities of Resv, the compound possesses limited oral bioavailability due to rapid
absorption and extensive metabolism, leading to metabolites such as glucuronidated and
sulfonated conjugates (Yang et al. 2015).
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Therefore, recent research has been shifted to similar activities exhibited by Ara-1 and
Ara-3, the prenylated analogs of Resv. In some cases, these biological activities surpass the
potency of their nonprenylated analogs. For example, Ara-1 had the highest efficacy in inducing
cell death in human leukemia HL-60 cells through the intrinsic apoptotic pathway (Huang et al.
2010). It was much more cytotoxic than Ara-3 and Resv with an EC50 of 4.2 uM compared to
17.6 uM, and its potency was likely attributed to the 4-isopentenyl moiety and the additional 3’hydroxyl moiety (Huang et al. 2010). According to the researchers, the isopentenyl group may
increase the hydrophobicity of the compound, thereby increasing compound interaction with the
cell membrane and increase cell update (Huang et al. 2010).
Bioavailability studies on Ara-1 and Ara-3 using the Caco-2 transport assay have not yet
been conducted until now. Most published research on the bioavailability of stilbenoids have
primarily focused on Resv. A study by Brents and colleagues (2012) found that Ara-1 and Ara-3
are metabolized to a lesser degree than its non-prenylated parent compounds, piceatannol and
Resv (Brents et al. 2012). Researchers suggested that the lipophilic side chains of Ara-1 and Ara3 may disrupt the glucuronidation process, thereby enhancing the compounds’ bioavailability
(Brents et al. 2012). However, results from the study differ than that of the present study. Though
data gathered from the present study do not confirm whether Ara-1 or Ara-3 are truly being
metabolized and to what extent, one can assume that the cells are interacting with the compounds
somehow to modify the structure of the parent compound. This is support by the observation that
the parent compounds are not recovered at any time point in the basolateral chamber, but are
rapidly decreasing as observed in the time course experiment in the apical chamber when in
contact with cells.
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Furthermore, another study by Brents and colleagues (2012) evaluated the activities of
eight human UDP-glucuronosyltransferases (UGTs) towards Ara-1, Ara-3, trans-piceatannol,
and trans-resveratrol. The findings indicated that prenylated stilbenoids may be preferable
alternatives to trans-resveratrol due to its slower metabolism. Whether Resv is metabolized more
in comparison to Ara-1 and Ara-3 cannot be confirmed in the present study, as the time course
stability of Resv with Caco-2 cells was not performed. However, one can infer that based on
previous results of Resv stability in PBS and WMEM in cell culture conditions in addition to
consistent transport to the basolateral chamber as positive control, that Resv may be metabolized
to a lesser degree compared to Ara-1 and Ara-3. Future studies are needed to elucidate if this is
the case.
The very same structural advantage that provides Ara-1 with higher efficacy of biological
activities may be the same feature that decreases its bioavailability. In a review by Chen and
colleagues, it is proposed that though the presence of a prenyl-moiety in a flavonoid makes the
backbone compound more lipophilic and enhances biological activity, it may also decrease its
bioavailability and plasma absorption (2014). Another important study by Xiao and Högger
highlighted the impact of structure on the stability of stilbenoids in cell culture conditions. It was
found that the glycosylation and methoxylation of stilbenoids enhanced the stability, and the
hydroxylation of stilbenoids decreased the stability (2015). Ara-3 shares the same structure as
Resv, except for the presence of a prenylated moiety, while Ara-1 possesses the prenylated
moiety in addition to an extra hydroxyl group (2015). This is supported by the low recovery of
Ara-1 from the apical chamber in the present study as well as the color change observed after 7
days in refrigerated storage. Specifically, Ara-1 in WMEM took on a dark brownish color
compared to Ara-3 in WMEM and WMEM alone. Ara-1 has an extra hydroxyl group on the B
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ring at the ortho position compared to Ara-3 or resveratrol. The more hydroxyl groups are
present, the more likely they are to be affected by oxidation, which could lead to quinone
formation. Quinones may bind to other quinones or proteins and other compounds, which in turn
leads to polymerization and subsequent color change.
Overall, more work needs to be done to elucidate the exact mechanism of what is
occurring between Caco-2 cells and Ara-1 and Ara-3 in the apical layer. A potential direction
that this research could take would be performing LC-MS and NMR on degradation products
observed during HPLC analysis. Additionally, if Ara-1 and Ara-3 are being oxidized, adding an
antioxidant to the apical chamber of the transport assay may potentially protect the compounds
long enough to be transported to the basolateral chamber.
Conclusion
In conclusion, Ara-1 and Ara-3 are not detected by HPLC in the basolateral chamber or
insert membranes and possess low recovery in the apical chamber after performing transport
assays with various transport buffers, preparation methods, and sample treatments over the
course of 3 to 4 h. This research demonstrates that Ara-1 and Ara-3 are not stable possibly due to
polymerization or degradation from the effects of oxidation, pH, and/or cellular interactions
between the compounds and Caco-2 cells during incubation.
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APPENDIX

Resv
RT: 5.2 min

Ara-3
RT: 13.6 min

Ara-1
RT: 10.6 min

Figure 1: HPLC chromatogram of arachidin-1, arachidin-3 and resveratrol as control in WMEM
at 340 nm.
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Figure 2: UPLC-MS/MS spectra of Ara-1 (A) and Ara-3 (B).
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Figure 3: HPLC chromatograms of Ara-1 from stock solution in WMEM at 78 ppm before (A)
and after 7 days of 5°C storage (B) at 340 nm.

60

A

Ara-3
RT: 15.2 min

2

B

Ara-3
RT: 14.8 min

2

Figure 4: HPLC chromatograms of Ara-3 from stock solution in WMEM at 78 ppm before (A)
and after 7 days of 5°C storage (B) at 340 nm.
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Figure 5: Original treatment solution made with 200 ppm Ara-1 in WMEM (A), 200 ppm Ara-3
in WMEM (B), and WMEM (C) stored after 7 days at 5°C.
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Figure 6: Change in pH of PBS and WMEM over 4 h in transport assay conditions at 37°C, 5%
CO2.
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Figure 7: Percent change in area of Ara-1 (n = 2) in PBS and WMEM at transport assay
conditions with standard error of mean bars (SEM). p < 0.05.
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Figure 8: Percent change in area of Resv (n = 2) in PBS and WMEM at transport assay
conditions with standard error of mean bars (SEM). p < 0.05.
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CHAPTER 4
Bioavailability of Bioactive Compounds in Blackberry Volatiles
Abstract
The use of berries and its components as functional ingredients have been on the rise,
especially due to antioxidant activities found in polyphenols. However, the bioavailability of
polyphenols tends to be low. Other plant metabolites such as volatiles tend to possess lower
molecular weight and lipophilic chemical structures, which may enhance bioavailability. An in
vitro Caco-2 model was used to determine the bioavailability of volatiles found in blackberry
essences. Blackberry essences were extracted from locally purchased blackberries, and a 1:1
dilution of blackberry essences combined with working cell culture media (WMEM) was applied
Caco-2 cells in semipermeable inserts to evaluate absorption and transport over a period of 0 – 4
h. 0.5 mL aliquots were taken from the basolateral chamber every hr and analyzed using
headspace solid phase microextraction gas chromatography (HS-SPME-GC). Individual volatiles
were tentatively identified and transport rates determined based on the peak area found in the
starting material. Results suggests that though esters and monoterpenes make up the two most
abundant functional groups in the blackberry essence profile, higher transport rates and recovery
were observed in aldehydes.
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Introduction
The latest research efforts have been focused on identifying dietary bioactive compounds
found in foods that have been shown to exert biological activities. Fruits, especially berries, can
be a rich source of antioxidants and polyphenols such as anthocyanins and phenolic acids (Nile
and Park 2014, Szajdek and Borowska 2008). Despite the well-known health effects of
anthocyanins and polyphenols, these compounds tend to possess poor bioavailability and their
stability can be affect by a variety of factors (Lila et al. 2016, Parisi et al. 2014). Other plant
metabolites such as volatiles show biological effects as well (Ayseli and İpek Ayseli 2016,
Pennerman et al. 2015). The attempt to discern the role of plant volatiles beyond its flavorcontributing attributes has gained momentum in recent years. As such, research studies that
explore the potential of volatiles to exert biological and pharmacological activities in human
health have begun to emerge.
In general, volatile compounds tend to be lipophilic in nature and possess molecular
weights lower than 300 Da and vaporize readily at room temperature (Kalua et al. 2007). If the
compound is sufficiently volatile, it is regarded as a smell or odor after it binds with olfactory
receptors in the nose (Kalua et al. 2007). Volatiles produced by plants are considered secondary
metabolites that help the plant survive in its environment. More than 100,000 chemical products
are known to be produced by plants, and 1,700 of these are categorized as volatiles (Spinelli et
al. 2011).
For much of history, the floral and vegetative parts of plants have been used to enhance
food quality and add to its organoleptic properties. Since then, the use of volatiles have expanded
to pharmaceutical, agricultural and chemical industries as flavorants, drugs, pesticides and
feedstocks (Schwab et al. 2008). Fruits, in particular, produce many volatile compounds that
contribute to their characteristic aroma and flavor (El Hadi et al. 2013). Plant-derived volatiles
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can be categorized according to their chemical structures, which include terpenoids, esters,
aromatics, amines, alcohols, aldehydes, ketones, all of which vary in their biological activities
and subsequent absorption once it has entered the body. Blackberries, in particular, are
dominated by esters and alcohols but also possess a wide variety of other volatiles that contribute
to its aroma and biological activities (D’Agostino et al. 2015, Meret et al. 2011). For example,
blackberry volatiles have been shown in a previous in vitro study to show significant modulation
of production of NO, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in a RAW264.7
macrophage cell model in comparison to six other berries (Gu 2018).
Perhaps the most important aspect of researching dietary bioactive compounds is to
determine the compounds’ bioavailability, or the extent to which a compound is absorbed and
distributed. The ability of a compound to exert its biological effects depends on its bioavailable
dose, rather than the administered dose. Limited research has been done on the bioavailability of
specific berry essences, or concentrated volatiles. Therefore, it is of interest to explore the
prospective health benefits of volatile and semi-volatile compounds found in blackberry
essences. The objective of this study is to assess the bioavailability of blackberry essences by
measuring and identifying individual volatile compounds transported across the Caco-2 cell
monolayer.
Materials and Methods
Materials
Blackberry essences were obtained from Dr. Luke Howard’s lab (University of Arkansas,
Fayetteville, AR). All materials were capped, tightly sealed and stored in amber glass bottles at 20°C until use.
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Headspace-Solid Phase Microextraction-Gas Chromatography- Mass Spectrometry
(HS-SPME-GC-MS) Profile of Blackberry Volatiles
HS-SPME-GC-MS analysis was conducted to determine the profile of blackberry
essences prior to experimentation. Frozen blackberry essences were first allowed to thaw to room
temperature. An 85 µm carboxen/polydimethylsiloxane, Stableflex, 24 Ga, manual SPME fiber
was then inserted into 20 mL glass headspace vial with 3 mL of blackberry incubated for 30 min
at 65°C with magnetic stirrer. Volatiles adsorbed to the SPME fiber were then desorbed at 270°C
for 2 min in the injection port of a Varian 3800 GC (Agilent Technologies, Santa Clara, CA,
USA) with a HP-5 (5% phenyl-methylpolysiloxane) column (30 m X 250 μm X 1 μm) (Agilent
Technologies, Santa Clara, CA, USA) connected to a Bruker (Billerica, MA, USA) model
Esquire-LC/MS ion trap mass spectrometer. For gas chromatography, the conditions were as
follows: flame ionization detector (FID) temperature kept at 280°C, total run time at 29 min, and
the fiber kept in the injection port for 10 min after each run. The injection port operated in
splitless mode with a constant helium flow rate at 25 psi. The initial temperature gradient was
25°C, held for 4 min, ramped at 12°C/min to 289°C, and held at 3 min. The mass spectrometry
analysis was performed in positive ion mode under the following conditions: capillary voltage at
4 kV with polarity [-] for positive ion 56 mode analysis, nebulizer gas pressure 30.0 psi, dry gas
flow of 9.0 mL/min, and a temperature of 300°C. Data were collected in full scan mode over a
mass range of m/z 50-1000 at 1.0 s per cycle.
Headspace Solid Phase Microextraction Gas Chromatography (HS-SPME-GC) of
Blackberry Volatiles in Transport Assay
The identification of individual blackberry volatiles collected during the transport assay
were subject to the same method as described above with the following modifications: an 85 µm

67

carboxen/polydimethylsiloxane, Stableflex, 24 Ga, manual SPME fiber was inserted into 4 mL
glass headspace vial with 0.25 mL of samples from all time points as well as the apical and
basolateral layer, and incubated for 30 min at 65°C with magnetic stirrer. Blackberry volatiles
were identified by GC-MS and further confirmed by retention indices using data of a n-alkane
mixture (C7-C20).
Cell Culture Maintenance
Caco-2 human colon cancer cells were purchased from the American Type Culture
Collection (ATCC, Rockville, MD, USA) at passage number 18. Cells were cultured according
to the protocol of Salyer and colleagues (Salyer et al. 2013) in Dulbecco’s modified eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% non-essential amino
acids, 2% antibiotic-antimicotic, and incubated at 37 °C in a humidified 5% CO2 atmosphere.
Cells were subcultured at 80-90% confluency.
Preparation of Cell Monolayers for Transport Assay
At 80-90% confluency, Caco-2 cells were trypsinized and seeded onto Transwell inserts
(polycarbonate membrane, 12 mm i.d., 0.4 μm pore size, Corning Inc., Kennebunk, ME) in 12well plates at a density of 1.0 × 105 cells/cm2.
The seeded Transwell inserts were treated with 500 uL and 1500 uL of WMEM on the
apical and basolateral side, respectively. Cells were allowed to grow and differentiate to form a
monolayer for 14-21 days post-seeding. The growing medium were replaced at days 3, 5, and
daily thereafter. Transepithelial electrical resistance (TEER) of cells grown in the Transwell
were measured using the Millicell ERS-2 voltohmmeter (Millipore Corp., Billerica, MA, USA)
to ensure cell monolayer integrity. Only monolayers with TEER values >400 Ωcm2 were used
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for further experimentation. Only passages 25-40 were used in this assay since a defined interval
of passages is recommended to ensure a consistent cellular phenotype in all experiments.
Transport Assay
In preparation for the transport assay, frozen blackberry volatiles were first allowed to
thaw to room temperature from -20°C. The stock solution was prepared by creating a 1:1 dilution
of WMEM warmed to 37°C and thawed blackberry essences immediately prior to
experimentation.
Prior to each assay, WMEM in both chambers was aspirated and 500 uL of the treatment
were added to the apical chamber in duplicate. Meanwhile, 1 mL of phosphate-buffer solution
(PBS) was added to the basolateral chamber.
To start the experiment, the system was incubated at 37 °C for 4 h. 500 uL samples were
drawn from the basolateral chamber every hr for up to 4 hr. The basolateral chamber was
replenished with 500 uL of PBS at each time point. At 4 h, remaining solutions in both chambers
were collected. The apical and basolateral chambers were then washed with 2000 uL and 1000
uL of PBS, respectively, pooled with the samples drawn at the 2 h time point and vortexed for 10
s. The stock solution as well as aliquots drawn from the apical chamber at the end of the
experiment were used to calculate mass balance.
The insert membrane was carefully peeled off with a tweezer and suspended with 0.5 mL
of ice-cold MQ water. The cell membrane was rinsed once more with 0.5 mL of ice-cold MQ
water. Then, 500 uL 1 N NaOH was added and the mixture was vortexed for 10 s to solubilize
cells from the membrane. All aliquots and cell membrane suspensions were frozen at -20°C until
further analysis.
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Statistical Analysis
All statistical analyses was performed using Statistical Analysis Software (System
Version 9.4; SAS Institute Inc., Cary, NC) using a one-way analysis of variance test (ANOVA).
Data was expressed as means + standard error of mean (SEM). A difference of p<0.05 was
considered significant.
Results
Headspace Solid Phase Microextraction Gas Chromatography- Mass Spectrometry
(HS-SPME-GC-MS) Profile of Blackberry Essences
Figure 1 is a GC-MS spectrum highlighting the numerous volatiles that make up the
complex profile of blackberry essence. Figure 2 categorizes the various functional groups that
are found in the blackberry essence profile. Abundance is as follows: esters (32%),
monoterpenes (25%), alcohols (13%), acids (11%), aldehydes (7%), ketones (7%) and other
unknown compounds (5%).
The tentative identification of individual volatiles found in the blackberry essence using
HS-SPME-GC-MS are listed in Table 1. The volatiles are arranged by retention time and
characterized by percent area of all peaks found in the essence profile. The observed retention
index (RI) was matched as closely as possible to the reported RI of the volatile as calculated
using data of a n-alkane mixture (C7-C20).
Headspace Solid Phase Microextraction Gas Chromatography (HS-SPME-GC) of
Blackberry Essences in Transport Assay
While the quantitation of each volatile recovered during the transport assay could not be
performed due to limited time and an incomplete range of standards for all blackberry volatiles
found in the essence, identification of the volatiles was performed by GC and further confirmed
by retention indices as previously shown. Figure 3 is an example of a GC chromatogram of
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blackberry volatiles at time point 0 h, 1 h, and 4 h from both the apical and basolateral chamber
during the transport assay. The changes in peak areas give a visual representation in the transport
of each compound as time progresses.
Table 2 is a summarized version individual berry volatiles during transport assays (n=19)
at time points 0, 1, 2, 3, and 4 h in both the apical chamber and basolateral chamber performed
using the same methodology as previously described. Since quantitation was not completed for
the individual volatiles, the percent area of each volatile found in the starting material was used
as a reference to determine transport instead. Each tentatively identified volatile in Table 2 is
arranged by retention time and observed RI after performing GC analysis. The column “percent
transported at each time point” refers to each volatile’s observed peak area at each time point
during the assay divided by the peak area in the starting material. The value is then multiplied by
100 to yield a percentage of how much of the volatile was transported and recovered at each time
point in comparison to the starting material. The column “percent area of starting material in
berry essence profile” refers to the peak area of that volatile divided by all other volatile peak
areas in the starting material and multiplied by 100 to yield a percent value. “% sum of area
recovered in basolateral chamber” refers to the percentage of how much of the starting material
was transported to the basolateral chamber, whereas “percent sum of total area recovered”
indicates the percentage of how much of the starting material was recovered during the transport
assay. Ideally, the values should add up to yield 100%; however, a percent mass balance is
simply impossible. In this case, numbers above or below 100% may be attributed to the
formation of byproducts. For example, a value over 100% could be that the breakdown product
of another volatile present in the blackberry essence turned into the volatile of interest. On the
other hand, a value under 100% could mean that the volatile of interest has been modified
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structurally or produced other breakdown products, therefore reducing the area of the total parent
compound. The volatiles with blank rows in the “percent transported at each time point” column
are those with peak interference from background noise, whether due to components of PBS or
WMEM co-eluting at the same time. Therefore, the values were omitted due to false responses.
Several volatiles were recovered at time point 0 h, which could be possible due to faulty
monolayer formation or incomplete tight junctions between the Caco-2 cells. Another
explanation is that the volatiles were low in molecular weight and/or highly lipophilic,
expediting passive transport almost immediately across the cell monolayer. Several volatiles high
in recovery at this time point include 1,3-benzenediol, 4-ethyl- or perilla alcohol, decanal, 2heptenal, α-terpineol and/or dodecane, and linalool (Table 2). 1,3-benzenediol, 4-ethyl is a
benzenediol with a low molecular weight of 124.139 g/mol, whereas decanal is a ten-carbon
aldehyde that occurs naturally and is used in fragrances and flavoring (Kim et al. 2016). 2heptenal is considered a fatty aldehyde lipid molecule, which may explain its affinity to cross the
cell membrane (Kim et al. 2016). Linalool, a terpene alcohol, was shown to possess Papp values
in the range of 2.6 × 10−6 to 1.8 × 10−4 cm s−1, indicating a bioavailability of more than 90%
(Heinlein et al. 2014).
At time point 1 h, 1,3-benzenediol,4-ethyl or perill alcohol, 2-propyl-1-pentanol and
several other volatiles found abundantly were detected. 2-Propyl-1-pentanol is a primary alcohol
with a molecular weight of 130.23 g/mol that peaks in transport at time point 1 h but tends to
decrease over time. The transport of 1,3-benzenediol, 4-ethyl is also highest at time point 1 h but
steadily decreases over time. Interestingly, linalool and decanal maintained somewhat consistent
transport over time. Several occurrences are observed at time point 2 h. The volatiles with the
highest percent of transport included 2-heptanone and 2-hexenol, which are not readily detected
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at other time points. They were also only observed in a small number of wells throughout the
transport assay; therefore, the data for these volatiles may be inconsistent. On the other hand,
aldehydes such as 2-heptenal, pentanals and the terpene alcohol linalool continue to transport
across the monolayer. Results from time point 3 h show that out of the top four most abundant
volatiles, three were aldehydes, specifically 2-hexenal, 2-heptenal and pentanal. 2-hexenal, is an
aldehyde that occurs in many plants and is responsible for the “green” smell and taste (Kim et al.
2016). Finally, the basolateral chamber at time point 4 had an usually high amount of
pinocarveol, which may be another example of inconsistent data due to its absence at every other
time point as well as the apical chamber. The next most abundant volatile was decanal, followed
by 2-heptenal and gamma-ionone – a high molecular weight sesquiterpenoid (192.3 gm/mol)
found in fruits and used readily in the fragrance and food industries (Kim et al. 2016).
Interestingly, gamma-ionone was detected at later time points compared to other abundant
volatiles, which could be due to its bulky structure and high molecular weight.
Overall, it appears that though monoterpenes and esters constitute the major groups of
compounds found in black berry essences, compounds belonging to aldehydes and alcohols
tended to yield the highest percentage of transport throughout the time points in the transport
assay. For example, decanal and 2-heptenal had the top two highest sum of percentage areas
recovered, followed by 1,3-beneznediol, 4-ethyl, linalool, heptanal and pentanal. However, the
sum of % areas for these volatiles were more than 100%, which may mean that other volatiles
may have had breakdown products that contributed to final yield.
Discussion
The aroma of berries play a major role in its overall quality in fresh or processed fruits. In
addition to its pleasant aromatic profile, berries also produce volatiles with functional properties
that help the plant survive in its environment. Research on the biological activities of plant
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metabolites have mostly been focused on polyphenols, especially antioxidants found within
berries. However, polyphenols are typically characterized by low oral bioavailability as
demonstrated by in vitro and in vivo studies. As of recent, biological activities exhibited by
volatiles (the concentrated form also known as essences) found in products such as essential oils
have garnered research interest. Volatiles found within blackberry essences, including
compounds such as linalool and nerol, have been shown to have antimicrobial and antioxidant
effects (Heinlein et al. 2014, Ladeira Coêlho et al. 2016). Structurally, volatiles tend to be
lipophilic and low in molecular weight, which could result in rapid absorption and transport
across the small intestine due to the affinity towards cell membranes. These characteristics could
give volatiles an advantage over compounds such as polyphenols and therefore having a higher
chance of eliciting biological activities, as a compound must be absorbed and distributed to have
an effect in the body. Currently, studies regarding the bioavailability of berry essences do not
exist, although the bioavailability of several volatile components have been elucidated.
In a study by Heinlein and colleagues (2014) investigating the permeability of hop aroma
compounds across Caco-2 monolayers, it was noted that nerol exhibited a high initial increase
and the beginning of a steady-state after 80 – 100 min, while linalool showed a slower increase
and an earlier steady-state after 60 min. The recovery percentages of nerol and linalool were
58.8% and 25.6%, respectively. In the current study, nerol was not found in the blackberry
essence profile, which could be due to many factors. This may include differences in cultivars,
environmental conditions during plant growth, soil composition, external stressors, and the like.
Linalool, on the other hand, was found in the blackberry essence profile. Although quantitation
of each volatile was not calculated due to limitations in the present study, an alternative was to
use the percentage of starting material as a reference when tracking the amount of volatile
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transported over time. Linalool has shown a relatively steady rate of transport throughout the
assay, which corresponded with the data from Heinlein and colleagues.
Other volatiles that exhibited high rates of transport tended to be structurally similar to
each other – specifically aldehydes such as decanal, 2-heptenal, heptanal, and pentanal. Heptanal
tended to decrease over time, indicating rapid transport initially but slowing down as the
transport assay continued. 2-heptenal fluctuated throughout the 4 time points, whereas decanal
and pentanal maintained a steady rate of transport. 1,3-benzenediol, 4-ethyl appeared in
abundance during the first two hr and slowed down as time went on.
In the future, more research needs to be done on the quantitation of individual volatiles
during transport assays. The mechanism behind volatile transport across the Caco-2 cell
monolayer will provide insight on how the compounds are absorbed in addition to determining
their permeability and potential metabolites responsible for biological effects.
Conclusion
In conclusion, even though monoterpenes and esters are readily found in the blackberry
essence profile, compounds categorized as aldehydes and alcohols tended to yield the highest
percentage of transport throughout the time points in the transport assay. This research
demonstrates that blackberry essence possesses a complex mixture of different volatiles, each
differing in their structure, biological activity, and absorption.
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APPENDIX
Table 1. Identification of individual volatiles and percentage area of total peaks found in blackberry essence using HS-SPMEGC-MS.
retention
time
(min)
5.68

% area

observed
RI

reported
RI

0.01

710

711

6.02

0.07

719

718

7.32

0.17

754

753

7.44
7.78
7.91
8.09
8.28
8.5
8.63
9.02

0.2
0.02
0.06
0.01
0.06
0.18
0.12
0.02

757
766
769
774
779
785
789
799

756
767
768
773
779
785
789
798

9.2
10.05
10.24
10.35

0.02
0.1
0.06
0.01

805
834
841
845

804
833
843
844

10.41

0.02

847

848

10.57
10.8
10.92
11.3

0.19
0.74
0.45
10.86

852
860
865
878

854
858
866
877

11.79
12.13

1.37
25.64

895
908

895
907

12.23
12.65

1.29
0.06

912
929

911
929

tentative identification
2-pentanone (methyl propyl
ketone)
acetoin (3-hydroxy-2butanone)
2-methyl-2-butenal or
pentanal
ethyl methylpropanoate
methyl 2 methylbutanoate
2-methyl-2-pentanol
toluene
3-methyl-2-buten-1-ol
dimethyl disulfide
1-hexen-3-ol
4-methyl-3-penten-2-one or 3hexanal
ethyl butanoate
3-ethoxy-1-propanol
1-(methylthio)ethanethiol
(e)-2-hexenal or ethyl 2methylbutanoate
ethyl-2-methylbutanoate
(e) 2-hexanal
3-hexenol (z)
3-methyl-2-butanone
isovaleric acid or 2,4dimethylthiazole
2-heptanone
formic acid, hexyl ester hexyl formate
4-methyl-1-hexanol
ethyl 3-hydroxy-3methylbutanoate

retention
time (min)

% area

observed
RI

reported
RI

15.39

0.17

1048

1048

ocimene

15.45

0.08

1051

1049

(z)-2-octenal

15.65

2.02

1060

1057

mesifuran

15.9
16.16
16.28
16.38
16.53
16.6
16.79
16.85

4.99
0.06
0.11
3.51
3.53
2.15
0.26
0.22

1072
1084
1090
1094
1102
1105
1115
1118

1072
1084
1089
1093
1100
1104
1115
1118

16.92
17.01
17.08
17.16

0.13
0.3
0.12
0.23

1121
1126
1130
1134

1122
1126
1131
1132

1-octanol
m-cresol, 3-methyl-phenol
guaiacol
2-nonanone
linalool
nonanal
1,3,8-p-menthatriene
p-cymenene or 2-phenylethyl
alcohol
trans-p-mentha-2,8-dienol
menthone
nerol oxide
limonene oxide

17.3

0.28

1141

1142

17.45
17.53
17.7
17.8

0.56
0.8
0.76
0.2

1149
1153
1161
1166

1149
1154
1162
1166

(e)-limonene oxide or α-fenchyl
alcohol
2-octyl acetate
nonanol
benzyl acetate or borneol
p-cymenol or (e,z)-2,6-nonadienol

17.92
18.06

1.08
0.48

1173
1180

1172
1179

(e)-linalool oxide
terpinen-4-ol

18.18
18.27

2.08
3.52

1186
1190

1187
1190

1-methyl-1-octanol, nonan-2-ol
dihydrocarveol

tentative identification
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Table 1. (Cont.)
12.75
12.87
13.05

0.05
0.09
0.15

934
939
946

935
939
946

13.17
13.3
13.4

0.12
0.05
1.03

951
956
960

953
960
963

13.52
13.6

0.25
0.16

965
969

965
968

13.71
13.93
14.09
14.23
14.31
14.46
14.56
14.65

1.24
1.07
0.25
0.55
0.65
0.65
0.32
2.74

973
982
989
995
998
1005
1009
1014

14.88
15.02
15.23

0.55
2.23
0.72

1024
1031
1041

RI: retention index

ethyl 3-hydroxybutanoate
α-pinene
1-isothiocyanato-butane or
pseudocumene
(+)-camphene
benzaldehyde
benzaldehyde

18.41
18.55
18.78

1.11
2.38
1.6

1198
1205
1218

1195
1203
1217

18.88
18.98
19.12

0.47
0.49
0.19

1224
1229
1237

1223
1229
1239

19.32
19.4

1.76
0.9

1249
1253

1250
1254

972
981
985
992
998
1006
1009
1014

3-octanone
ethyl isohexanoate, 4-methyl
pentanoic acid ethyl ester
sabinene or trans-2-pentenol
octanol
sulcatone
β-myrcene
4-carene
octanal
3-carene
hexyl acetate

19.47
19.77
19.99
20.21
20.31
21.35
21.67
23.23

0.79
0.41
0.1
0.46
0.15
0.96
1.11
0.96

1257
1274
1286
1299
1305
1364
1383
1478

1256
1275
1287
1299
1302
1364
1382
1477

1027
1033
1041

p-cymene
limonene
acetophenone

25.15
25.3
26.32

1.1
0.16
0.15

1603
1613
1685

1604
1614
1685

α-terpineol
myrtenol
(e)-carveol or (e,e)-2,4nonadienal
linalyl formate
(z)-carveol
hexyl 2-methylbutyrate or
benzothiazole
(z)-2-decenal
carvone
bornyl formate or p-anisyl alcohol
perilla aldehyde
4-ethylguaiacol
gamma butyrolactone
nonyl acetate
eugenol, 4-allyl-2-methoxyphenol
geranyl acetate
r-δ-decenolactone or linalyl
isovalerate
cedr-8(15)-en-9-ol
(e)-2-hexenoic acid
γ-dodecalactone
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Table 2. Summary of individual berry volatiles recovered during transport assay at time points 0, 1, 2, 3, and 4 h.
% transported at each time point
retention time
(min)
3.5
4.3
4.9
6.6
7.3
8.3
9.1
9.4
10.1
10.6
10.9
11.5
11.9
12.2
12.3
12.6
12.9
13.4
13.6
14.7
15.2
16
16.2
16.6
17
17.3
17.6
18.1
18.5
18.7
18.9
19.2
19.5
20
20.3
20.6
22.5
24.5
26.6
29.5

observed RI
656
706
723
771
791
822
846
855
877
892
902
923
937
947
951
961
972
989
996
1040
1060
1092
1100
1117
1135
1148
1161
1183
1200
1209
1218
1232
1245
1268
1282
1295
1347
1400
1507
1700

tentative identification
acetic acid
pentanal
butanoic acid, methyl ester
toluene
hexanal
pentanoic acid, methyl ester
2,3-dimethyl-1-pentanol or 3-hexanol, 5-methyl2-hexenal
2-hexenol
2-heptanone
heptanal
2-heptanol
4-methylheptan-2-one
2-heptenal
2-heptanone, 4-methyl
benzaldehyde
1-octen-3-ol
unknown
5-hepten-2-ol, 6-methyl- (sulcatol)
2-propyl-1-pentanol
2-nonenal (e)
4-methyl-benzaldehyde
linalool
nonanal
hexanoic acid, 2-ethylpinocarveol
borneol
terpinen-4-ol
alpha terpineol and/or dodecane
decanal
benzaldehyde, 2,4-dimethylmyrtenal
nonanoic acid
butanoic acid, heptyl ester
butanoic acid, heptyl ester
1,3-benzenediol, 4-ethyl- or perilla alcohol
gamma-ionone
tetradecane
2,4-di-tert-butyl phenol
2-hexadecanol

RI: retention index (n=19).
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T0

T1

T2

T3

T4 Baso

T4 Api

% area of starting
material in berry
essence profile

% sum of area
recovered in
basolateral chamber

% sum of total
area recovered

23.1
3.1
0.0
4.9
0.0

17.8
3.7
13.2
8.5
0.0

29.9
3.6
0.0
10.4
0.0

26.8
4.1
29.6
8.7
0.0

15.8
3.1
14.0
0.0

8.7
0.0
32.2
11.8
73.2

2.7
14.6
2.4
6.2
0.5

90.3
14.5
56.8
27.7
0.0

122.1
17.6
89.0
44.4
73.2

27.7
0.0

0.0
0.0

0.0
72.8

32.9
0.0

0.0

35.6
37.1

1.1
0.7

32.9
72.8

96.2
109.9

17.3

14.0

18.5

15.0

0.0

58.8

2.6

47.5

123.6

37.8
0.0
0.0
0.0
0.0
8.0
0.0
0.0

0.0
0.0
0.0
10.5
0.0
9.7
31.0
0.0

34.7
89.1
0.0
0.0
0.0
8.7
28.1
0.0

29.9
0.0
0.0
0.0
0.0
6.6
14.2
16.0

25.6
0.0
0.0
0.0
0.0
3.8
17.0
0.0

26.6
0.0
0.0
0.0
0.0
3.4
9.1
11.6

1.1
0.6
0.4
2.7
1.9
10.4
3.3
2.5

90.3
89.1
0.0
10.5
0.0
28.7
90.4
16.0

154.7
89.1
0.0
10.5
0.0
40.1
99.5
27.6

30.2

17.2

25.2

21.8

15.3

31.7

1.8

79.4

141.4

0.0

0.0

0.0

0.0

98.8

0.0

1.1

98.8

98.8

33.8
38.3

14.5
30.9

11.6
22.2

10.0
15.6

11.0
40.7

17.0
33.4

3.8
2.5

47.1
109.5

98.0
181.1

0.0

0.0

0.0

0.0

0.0

77.8

0.6

0.0

77.8

4.0

6.2

5.6

5.6

0.0

0.0

6.7

17.4

21.4

45.1
8.5

60.5
0.0

14.0
11.3

10.8
8.5

0.0
17.8

21.1
13.3

4.0
3.6

85.3
37.6

151.5
59.4

Figure 1. GC-MS chromatogram of blackberry essence profile.
Ketones
7%
Monoterpenes
25%

Esters
32%
Other
5%

Acids
11%
Aldehydes
Alcohols
7%
13%
Figure 2. Distribution of functional groups found in blackberry essence profile.
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A

B

C

D

Figure 3. GC chromatogram of blackberry volatiles at various time points during the transport
assay. (A) 0 h from basolateral chamber; (B) 1 h from basolateral chamber; (C) 4 h from apical
chamber; (D) 4 h from basolateral chamber.
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CHAPTER 5
Overall Conclusion
This study demonstrated that Ara-1 and Ara-3 are not detected by HPLC in the
basolateral chamber after performing transport assays with various transport buffers, preparation
methods, and sample treatments over the course of 3 to 4 h. Overall, the stability of both
compounds may be decreased due to polymerization or degradation from the effects of oxidation,
pH, and/or cellular interactions between the compounds and cells during incubation conditions.
Further research is necessary to ascertain why the use of Ara-1 and Ara-3 during cell culture
assays may pose issues with stability and recovery. Additionally, the exact mechanism of the
interaction between Caco-2 cells and Ara-1 and Ara-3 in the apical layer should be elucidated.
Regarding the bioavailability of blackberry essences, compounds categorized as aldehydes and
alcohols tended to yield the highest percentage of transport throughout the time points in the
transport assay. Though monoterpenes and esters comprise the two largest functional groups in
the blackberry essence profile, compounds that are less bulky and lower in molecular weight
tended to transport at higher rates in comparison. This study demonstrates that blackberry
essence possesses a complex mixture of different volatiles, each differing in their structure,
biological activity, and absorption. Therefore, more research in this area needs to be conducted
for a clearer understand on the apparent permeability of each volatile.
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